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This thesis presents a highly sensitive genome wide search method for recessive muta-
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homozygous regions between the cohorts. The method is demonstrated by comparing col-
orectal cancer patients against unaffected references. The objective is to find homozygous
regions and alleles that are more common in cancer patients.
We have designed and implemented software tools to automate the data analysis from
genotypes to lists of candidate genes and to their properties. The programs have been
designed in respect to a pipeline architecture that allows their integration to other programs
such as biological databases and copy number analysis tools. The integration of the tools
is crucial as the genome wide analysis of the cohort differences produces many candidate
regions not related to the studied phenotype.
CohortComparator is a genotype comparison tool that detects homozygous regions and
compares their loci and allele constitutions between two sets of samples. The data is visu-
alised in chromosome specific graphs illustrating the homozygous regions and alleles of
each sample. The genomic regions that may harbour recessive mutations are emphasised
with different colours and a scoring scheme is given for these regions.
The detection of homozygous regions, cohort comparisons and result annotations are all
subjected to presumptions many of which have been parameterized in our programs. The
effect of these parameters and the suitable scope of the methods have been evaluated.
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haplotypes and they can be used within the same study.
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Abbreviations and Symbols
aa homozygous combination of alleles A and A
ab heterozygous combination of alleles A and B
bb homozygous combination of alleles B and B
bp base pair
C{F} region matrix of compound heterozygotes (F=filtered)
CGH comparative genomic hybridisation
CRC colorectal cancer
CSC Center for scientific computing (CSC - Scientific Computing Limited)
d the minimum number of homozygous SNPs required between two heterozy-
gous ones
DNA deoxyribonucleic acid
g maximal rate of heterozygosity
GO Gene ontology
h{D,R} probability of having a homozygous region at a certain region (D=patient
data, R=reference data)
HMM hidden Markov model
k number of measured SNP loci
l{D,R} minimum length of regions accepted (D=patient data, R=reference data)
LOH loss of heterozygosity
Mbp mega base pairs = 1 000 000 bp
MM mismatch probe
n number of samples
PM perfect match probe
R{l,gd,sw,D,R} region matrix containing 1 for homozygous SNP and 0 for heterozygous
SNP (l=filtered with l, gd=gap distance model, sw=sliding window model,
D=patient data, R=reference data)
MIAME Minimum information about a microarray experiment
RNA ribonucleic acid
S{D,R} sample matrix of SNP haplotypes (D=patient data, R=reference data)
s maximal length of a heterozygous gap within a homozygous region
SNP single nucleotide polymorphism
t{D,R} number of overlapping homozygous regions (D=patient data, R=reference
data)
w length of the sliding window given in SNPs
11 Introduction
Cancers are life threatening diseases that are becoming more common as people live
longer [AD04]. There are several factors affecting the development of a cancer. For
example some chemicals, such as tobacco, asbestos, radioactive substances, and benzene
are well known for their cancer inducing properties but it is also known that environmental
factors such as sunlight and other ionizing radiation may also contribute to the develop-
ment of the cancer. Yet another well known fact is that some viral infections may lead to
cancer [Wei06]. A common property of all cancer causing agents is their ability to alter
the cellular DNA content. The alteration may be caused by either a direct damage to the
molecule itself or it can be a stress mediated process in which other cellular processes are
disturbed decreasing the ability of the cell to maintain its genomic integrity.
The genetic origin of cancers and the variation between the individual genomes partly
explains why some people are more subjected to certain types of cancers. It has been
shown in many studies that some families are carrying mutations increasing their risk of
cancer [Knu71, Sal00, HP04, Vie06, Web06]. The awareness of such mutation helps in
screening the risk groups and to treat them in a more precise manner. The identification
of mutations and the affected genes is essential to achieve new diagnostics and therapies.
The detection of cancer related mutations provides a challenging task for bioinformatics
as the human genome contains over 21000 know genes [Bir06]. High throughput geno-
typing methods such as single nucleotide polymorphism oligonucleotide arrays described
in Section 3.1 can be used for the genome wide analysis of the DNA samples. The data
processing tools described in this thesis can be used to process the vast amount of the data
generated by the new measurement techniques.
The amount of publicly available genotype data increases as many journals1 presume the
release of original measurements for the articles referring to such data. Minimum In-
formation About a Microarray Experiment (MIAME) [Bra01] defines a guideline stating
what kind of background information should be provided along the microarray measure-
ments to make them reproducible. The information consists of experiment details such as
sample and probe descriptions that are essential for the analysis of the data. The interna-
tional HapMap [The03] project collects information about genotype frequencies in human
populations and the data is publicly available on their Internet site. HapMap information
can be used to select genetic markers suitable for the population under concern.
This thesis focuses on the process of refining the SNP haplotype data into something with
1For example: Bioinformatics, Nature, and PLoS Genetics
2more biological relevance such as scored and annotated lists of regions with significant
difference to controls. The differentiated region of samples will in turn guide further ex-
perimentation and sequencing of the prospective DNA segment. The implementation of
a SNP data set visualisation and comparison tool play an important role in this thesis.
The key thing is to find a sensitive method to detect homozygous regions and to compare
them between the two sets of data. The interest is not only in those homozygous regions
that are heterozygous in controls but we are also keen in locations with different allele2
compositions or significant overlapping homozygous deletions. It was found in the pre-
liminary phase of the project that straightforward statistical analyses with exact p-values
are not efficient means to address the sensitivity requirements. A scoring schematic with
gene annotations was found to be a better alternative. The major objective of the project
is to find potential regions harbouring inherited mutations in cancer predisposing genes.
Based on results emerging from developed algorithm experimentally focused scientists
can then choose the best candidates for the wet lab verifications.
Annotations of the regions in D:/resCRC_tmp/out/InterestingRegions.txt:
 - 5: 27983508-29542122 (227971)
   5: 28660521-28660629    ? (NOVEL): snRNA_pseudogene, 1 exon(s), prob...
   5: 28961464-28963453    ? (NOVEL): protein_coding, 1 exon(s), probes...
   5: 28963655-28963873    ? (NOVEL): protein_coding, 1 exon(s), probes...
   5: 29106339-29106474    snoACA18 (NOVEL): snoRNA, Small nucleolar RN...
 - 9: 33649571-36846268 (206063)
   9: 33665438-33666649    PTENP1 (KNOWN): protein_coding, Phosphatase ...
   9: 33740515-33789230    PRSS3 (KNOWN): protein_coding, Trypsin-3 pre...
   9: 33807182-33910402    UBE2R2 (KNOWN): protein_coding, ubiquitin-co...
   9: 33820976-33821075    Y (NOVEL): misc_RNA, Y RNA [Source:RFAM;Acc:...
   9: 33858537-33858665    ? (NOVEL): snRNA_pseudogene, 1 exon(s), prob...
   9: 33911691-34038947    UBAP2 (KNOWN): protein_coding, ubiquitin ass...
   9: 34039964-34040212    ? (NOVEL): snRNA_pseudogene, 1 exon(s), prob...
   9: 34076386-34116771    WDR40A (KNOWN): protein_coding, WD repeat do...
   9: 34159687-34159934    ? (NOVEL): pseudogene, 2 exon(s), probes: [H...
   9: 34169003-34242521    UBAP1 (KNOWN): protein_coding, Ubiquitin-ass...
   9: 34184812-34184905    Y (NOVEL): misc_RNA, Y RNA [Source:RFAM;Acc:...
   9: 34185642-34185883    ? (NOVEL): pseudogene, 2 exon(s), probes: [H...
   9: 34191271-34191513    ? (NOVEL): pseudogene, 3 exon(s), probes: [H...
   9: 34196155-34196239    ? (NOVEL): rRNA_pseudogene, 1 exon(s), probe...
   9: 34242379-34301369    C9orf48 (KNOWN): protein_coding, 22 exon(s),...
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Figure 1: An overview of the data inputs (blue arrows) and outputs (red arrows). Genotype
information of two sample sets is visualised in chromosome specific figures. The homozygous
regions and their differences in sample sets are listed into text files. RegionAnnotator assigns gene
annotations for each interesting region. The gene list can be further coupled with other biological
databases or literature.
The analysis of genotype data is based on two sets of data. The samples are divided
into these two categories based on the phenotype of individuals that is their observable or
measurable traits. The detection of interesting genomic differences between the sample
sets is based on the assumption that the phenotype may be caused by a recessive mutation
2An allele refers to a certain nucleotide at a certain locus
3in some samples. Only homozygous deletions are analysed due the unrelated nature of
samples and because the analysis has been conducted using the genotype data. Methods
requiring parent-offspring trios [Con06] are clearly unsuitable but the integration of chro-
mosomal copy numbers may improve our results as explained in Section 8. A phenotype
criterion of colorectal cancer has been used in this study but the comparison methods are
presumably applicable to other phenotypes also.
42 Cancer Genetic Background
A short introduction to the necessary biological concepts in colorectal cancer is given
in this section. The means of genetic variation are explained as they affect the analysis
but the detailed mechanisms of inheritance and gene regulations are not explained in
this paper. Good sources of additional cancer information are for example [Wei06] and
[VK02].
2.1 Introduction to cancer biology
Cancer in this thesis is defined as malignant neoplasia, which is a genetic disorder in
cells. Cancer cells are dividing in an uncontrolled manner and invading to new tissues.
The invasion may concern the neighbouring tissues or some more distant parts of the body
in which case the invasion is referred as metastasis. Approximately 90% of cancer victims
are killed by the metastases making them far more dangerous than the primary tumours
[HW00].
Cancer cells are not only multiplying in an uncontrolled manner but they can also induce
vascular growth, escape immune system and avoid apoptosis [HW00]. Apoptosis is a pro-
cess of programmed cell death that is usually triggered when the cell is either subjected
to overwhelming stress such as virus infection or DNA damage or detected by the im-
mune system [KF00]. The transformation from a normal cell to a cancer is usually due
the accumulation of mutations leading to all required properties [Fea98, p. 229]. The
amount of initial mutations in cancers varies typically from two to about ten but they tend
to accumulate during the progression of the disease and the number of mutated genes in
mature tumours reaches an average of about 90 [Sjö06]. Germ cells and their predeces-
sors, so called germ line cells, may pass their mutations to subsequent generations. Cells,
other than those in a germ line are called somatic cells. The first mutations may have been
inherited from the parents as a hereditary mutation and the second mutation may occur
in somatic cells [Knu71, MK06]. It is possibly that mutations have occurred in somatic
cells, in which case the cancer is sporadic. Loss of heterozygosity (LOH) occurs when
the originally heterozygous tumour cells become homozygous for a locus and the allelic
contribution of the other parent is lost. The second mutation is usually a LOH that can
be caused by a deletion in homologous chromosome or by a mutation that removes the
difference between alleles.
The concept of gene has become ambiguous as a wide variety of cellular DNA func-
5tions have been discovered [Pea06]. Here, gene is used to refer transcripts (that are RNA
products of expressed genes) of any kind. All genetic variations affecting the cancer sus-
ceptibility are of our interest and thus no distinctions are made between protein coding
genes and other transcripts like microRNAs [Gar06]. The sequence annotations are based
on transcripts available in Ensembl database as described in Section 5.
The most dramatic cancer causing mutations are usually affecting oncogenes, DNA repair
genes, or tumour suppressor genes. Oncogenes are cancer-inducing genes [Wei06, p.
G:14] and they are usually up-regulated in cancer cells. The function of oncogenes is
typically related to control of the cell differentiation and proliferation. Changes in DNA
repair genes may decrease their activity and promote further alterations in genome thus
increasing the chance of developing a cancer. Typical, tumour suppressor genes encode
proteins that regulate the growth of the cell. The function of tumour suppressor genes
is complementary to oncogenes in a sense that they inhibit processes responsible for the
cancerous behaviour of the tumour cell. Inactivation of the tumour suppressor genes may
promote the cancer genesis. Phenotypic changes in tumour suppressor genes require a loss
of both copies in a region of the gene since the inactivation of the gene in one chromosome
is usually compensated by the unaffected gene in the homologous chromosome.
Colorectal cancer (CRC) is the third common type of cancers [Ame06, Fin05]. There
were about 2300 new cases diagnosed and 1100 persons died because of CRCs in Fin-
land during the year 2003 [Fin05]. The risk of getting a CRC is doubled if it has been
diagnosed from a first degree relative and even four times the average if the relative was
younger than 45 years old at the time of the diagnosis [JH01]. Those who have inherited
a cancer predisposing mutation are more likely to develop cancer and they may do so
while younger because they already have the initial mutation. Mutant carrying cells need
less (and may be more prone to) somatic alterations in order to become malignant. Sev-
eral genes are known to increase CRC risk if they are mutated (for example APC, MYH,
SMAD4, ALK3, STK11/LKB1 and DNA mismatch repair genes) [Web06]. Still, a fraction
of the families of CRC patients may harbour mutations in genes that are not known to
be cancer predisposing [Aal]. The effects of an ancient recessive mutation can be seen in
those who have inherited the mutation from their both parents that are descendants of the
person who had the original mutation.
Isolated populations with extensive and reliable genealogical records are ideal for genetic
studies of hereditary diseases [PJV99, VP04, MK06]. Suitable populations can be found
for example from Quebec, Iceland, Northern Sweden, and Finland [VP04]. The chance of
consanguineous parents increases in these populations and thus recessively heritable phe-
6notypes are seen more frequently. The genealogical records can be used to map certain
genotypes to mutant carrying individuals if the affected people are close relatives and the
records are available. The methodologies of these linkage studies are further discussed in
Section 2.3. In this study we have concentrated on developing an autozygosity mapping
method suitable for surveys of distantly related individuals. We assume an isolated popu-
lation in order to attain a reasonable chance of autozygosity while the number of required
samples is kept in minimum.
2.2 Mutations and markers
Cellular DNA is packed into highly coiled molecules called chromosomes. Homo sapiens
is a diploid species since it has two copies of each homologous chromosome. Homolo-
gous chromosomes are corresponding chromosomes with a common origin and they have
separate copies of the same genes. The length of the chromosomes varies between 47 and
247 Mbp having total of over 3433 Mbp [Bir06]. The whole genome consists of 23 pairs
of chromosomes 3. All but one (1–22) of these pairs are autosomes and the last pair (23)
consists of sex chromosomes. Autosomes are chromosomes that are not responsible for
the gender of an individual. The normal diploid constitution of sex chromosomes is either
a pair of two X chromosomes (female) or one X and one Y (male).
Recombination of the sections of chromosomes takes place during the production of germ
cells (meiosis). The regions of chromosomes that are inherited in continuous pieces are
called haplotypes. The original haplotype of the person who got the mutation degrades to
ever smaller fractions as the generations go by and it gets mixed with the other haplotypes.
The various aspects of haplotypes are further discussed in Section 4.4.
The mutation itself creates some variation to the genome of the population but it is also
surrounded by a vast amount of other mutations that have accumulated during the evolu-
tion in the context of its haplotype. The frequency of mutations to be inherited together
is called linkage and two alleles are said to be in linkage disequilibrium if their linkage is
greater than what would be expected for the independent alleles. The variation in DNA
may consist of deletions where some pieces are missing, insertions of new genetic ma-
terial or changes in nucleotides, where a sequence is changed to another. Most of the
variation in human genome consists of substitutions in single nucleotide, where one of
the four nucleotides (adenosine, thymine, guanine, and cytosine) has changed to another
3To be precise, each mitochondrion has its own copy of an additional chromosome but these extranuclear
chromosomes are ignored in this thesis
7one. The phenomenon of having such a varying nucleotide at a certain locus is referred
as single nucleotide polymorphism (SNP). Some of these alterations have been associated
to certain phenotypes [The03]. Common definition of the SNP requires that the relative
frequency of the least frequent allele is greater than 0.01 [Moo05]. The development of
the high throughput methods of detecting these SNPs has given us a chance to trace hap-
lotypes based on their SNP content. An example of a mutation haplotype is illustrated in
Figure 2. Individuals A and B share a mutation between the SNP2 and SNP3. The pheno-
type effects of the mutation can be seen in both individuals if the mutation is dominant.
Individual A expresses no recessive mutations as the mutation is not present in chromo-
some A2. A recessive mutation can be restricted to the right side of SNP1 since SNP1 is
heterozygous in B. The detection of the mutation requires a complete sequencing of the
DNA between SNP1 and a marker that follows SNP3 but has not been associated to the
same haplotype.
5’ ...ACATGTTCACTGCTGCTTCTGGAGAGTGGCTCCCAAACACCCCCAGGTCCAGCCATCATT... 3’
3’ ...TGTACAAGTGACGACGAAGACCTCTAACCGAGGGTTTGTGGGGGTCCAGGTCGGTAGTAA... 5’
A1
A2
5’ ...ACATGTCCACTGCTGCTTCTGCAGAGTGGCACCCTCAGACCCCAAGGTCCAGCCATCATT... 3’
3’ ...TGTACAGGTGACGACGAAGACGTCTAACCGTGGGAGTCTGGGGTTCCAGGTCGGTAGTAA... 5’
heterozygous mutation
B1
B2
5’ ...ACATGTTCACTGCTGCTTCTGCAGAGTGGCACCCTCAGACCCCAAGGTCCAGCCATCATT... 3’
3’ ...TGTACAAGTGACGACGAAGACGTCTAACCGTGGGAGTCTGGGGTTCCAGGTCGGTAGTAA... 5’
homozygous mutation
5’ ...ACATGTCCACTGCTGCTTCTGCAGAGTGGCACCCTCAGACCCCAAGGTCCAGCCATCATT... 3’
3’ ...TGTACAGGTGACGACGAAGACGTCTAACCGTGGGAGTCTGGGGTTCCAGGTCGGTAGTAA... 5’
C1
C2 wild type homozygote
5’ ...ACATGTTCACTCCTGCTCTGCGAGAGTGGCTCCCAAACACCCCCAGGTCCAGCCATCATT... 3’
3’ ...TGTACAAGTGACGACGAAGACCTCTAACCGAGGGTTTGTGGGGGTCCAGGTCGGTAGTAA... 5’
5’ ...ACATGTTCACTGCTGCTTCTGGAGAGTGGCTCCCAAACACCCCCAGGTCCAGCCATCATT... 3’
3’ ...TGTACAAGTGACGACGAAGACCTCTAACCGAGGGTTTGTGGGGGTCCAGGTCGGTAGTAA... 5’
SNP1 SNP2 SNP3
Figure 2: Illustration of the relationship between SNPs and haplotypes. Three SNPs measured
from 3 individuals (A, B, and C) are listed with two strands of DNA (green and yellow) and
two chromosomes (1 and 2). The varying alleles for the SNPs in 5’-strand are: SNP1 ∈ {C, T },
SNP2 ∈ {C,G}, and SNP3 ∈ {A,C}. The mutation is associated to haplotype of SNP2 = C and
SNP3 = A.
Recessive phenotypes are expressed if a mutant allele is inherited from both parents. The
chromosomal regions that have the same alleles in both homologous chromosomes are
called homozygous (a more detailed definitions of the homozygous region are given in
Section 4.1). Identification of a homozygous region from affected individuals suggests
the existence of a causative mutation within the region [MK06]. A homozygous region
8is called autozygous if both copies of the allele are inherited from the common ancestor.
A chromosomal region is called hemizygous if the genome contains only one copy of an
allele and its homologies. Hemizygous cells might have lost a chromosome or its frag-
ments. Homozygous regions can be caused by a somatic LOH or as typically, because of
autozygosity. We do not make difference between homozygous and hemizygous regions
and thus we denote aa = {AA, A}, bb = {BB, B}.
The vast majority of the human genome is homozygous in a sense that the sequence is
identical in both homologous chromosomes. The similarity of the sequences is especially
noted for genes and other evolutionary conserved parts of the genome. Even those loci
that vary between individuals are likely to be homozygous as one of the alleles may be
more common than the others. Distributions of two alleles can be estimated using the
binomial distribution if a random mating is assumed within the (infinitely large) pop-
ulation as stated by Hardy-Weinberg principle [Ste43]. The genotype frequencies are
f (aa)= f (a)2, f (ab)= 2 f (a) f (b), and f (bb)= f (b)2, where f () refers to the frequency of
the allele or the genotype.
2.3 Detection of cancer related mutations
In this section we describe how cancer related mutations are studied in traditional cancer
biology. First, we illustrate the concept of linkage studies and the use of pedigrees in them.
Second, we describe how to find mutations using genotype data and smaller pedigrees.
The distant relatedness of the patients and the paucity of pedigrees form a difference
between the scopes of linkage and association studies such as the CRC study described in
this thesis.
The detection of a cancer related mutation is usually motivated by the observation of
several similar cancers in different individuals. Traditionally, relationships between the
patients are used to trace possibly inherited mutations [Mid04, MK06, Vie06]. The pedi-
grees can be sorted out using the knowledge about the ancestors and offspring of the
patients. Information about phenotypes is bind to pedigrees in order to identify lineages
of mutant inheritance. Some ancestors of the affected individuals may be identified as
carriers of the mutation under the hypothesis that the mutation exists. The number of the
mutant carrying individuals that develop a cancer and gets diagnosed depends on the age
of the individuals [AD04] and the penetrance of the mutation [HP04]. Most cancers are
not caused by germ line mutations [Lic00]; especially they are not necessarily affected
by the same mutations [Sjö06]. Some people may have developed a cancer due a series
9of somatic mutations and they may be identified as separate family lineages or they may
confound the analysis producing misleading patterns of inheritance.
Genome wide sequencing of the patient samples would be too laborious with the current
techniques and thus some marker (microsatellites or SNPs) based heuristics [Abe02] are
used to infer haplotypes that may contain the mutation. First, haplotype patterns of mark-
ers in linkage disequilibrium are constructed. Secondly, haplotype patterns are compared
against the pedigrees to identify patterns that would explain the observed phenotypes.
Haplotypes that match the patterns of affected individuals can be used to identify chro-
mosome regions with possible mutations. The biological content of the region can be
fetched from biological databases as explained in Section 5. Functional experiments can
be conducted to see whether some of the genes found from the regions are differentially
expressed in cancer patients in comparison to unaffected individuals. The sequences of
differentially expressed genes should be compared in order to identify the actual genetic
difference between the haplotypes.
A good example of the described cancer gene detection methods can be found from pi-
tuitary adenoma study [Vie06], where a mutation of AIP gene was found from people in
Northern Finland. The affected people were found to be members of two family lineages
suggesting a germ line mutation.
The linkage based detection of mutations with a low penetrance requires a vast number
of samples from affected siblings, which can be attenuated by the methods used in as-
sociation studies [HP04]. The association methods can be used for the identification of
polygenic susceptibilities as the risk of cancer can be posed by a set of alleles [Web06].
None of the alleles is necessarily highly penetrative but their combination may cause a
significant increase in the cancer predisposition [HP04]. Relative frequencies of haplo-
types between case and control samples can be compared statistically if there are enough
samples [Onk02]. The haplotypes, which are more frequent in case samples may con-
tribute the observed phenotype.
Recessively inherited mutations should be identifiable in autozygous regions of those ex-
pressing the phenotype [LB87]. The autozygous regions can be identified from the geno-
type sequences produced by the SNP-microarray experiments but unfortunately current
solutions assume close relatedness of the samples [GT02, Woo04, Chi06]. In this thesis,
we proposed a new procedure for unrelated samples. The procedure scales to high density
array data sets of hundreds of samples. The method takes genotyping errors into account
and it can be adjusted to non-uniform marker distributions.
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3 High Throughput SNP-microarray Analysis
Single nucleotide polymorphisms are one of the most abundant genetic variations among
humans [Moo05]. The vast number of SNPs causes a challenge for biologists and bioin-
formaticians although they provide lot information about the relationships between indi-
viduals. Genomic variation is traditionally analysed using microsatellite markers [WCK06].
Microsatellites are short, highly repetitive DNA sequences and their length varies among
the individuals. The SNPs are not as informative markers as longer sequences but the
vast density and potential for automation makes them useful in genetic studies [Wan98].
The appearance of new microarray methods has provided a cost-efficient way to analyse
over 106 SNPs from one sample. The haplotype information provides insight into evo-
lutional backgrounds of the populations. HapMap [The03] is an extensive international
project collecting information about the genetic variation among the humans. The pop-
ulation based information about the allele frequencies can be used to trace origins of the
differences.
The SNP-microarrays are used for example in chromosomal copy number analysis, link-
age analysis [Mid04], LOH detection [Ber06, LT00, Lin04, ZPH05], and in general geno-
typing. An SNP-microarray experiment produces an estimate of the allele concentrations
for each SNP. The concentrations are relative to each other (see normalization in Sec-
tion 3.2). The genotype analysis is based on a comparison between the expected alleles,
where equal strength of the signals of both alleles indicates heterozygosity and the hy-
bridisation of one allele is considered a homozygous SNP. The copy number analysis is
based on more accurate comparison of the concentrations to predict the multiples of al-
leles [Nan05, Tin06, Zha04, Zha05]. Tools and resources available for the SNP marker
studies are reviewed in [Moo05], which gives a more detailed overview of biological po-
tential of SNPs.
3.1 SNP oligonucleotide array
The use of microarrays has been in a rapid expansion in biological and medical research
ever since their invention in late 1980’s. SNP-microarrays provide a relatively fast and
inexpensive genotyping method, which requires only tiny amounts of DNA. Different
kinds of technologies are used in SNP-microarray production and platforms vary in their
hybridisation and staining techniques [Aff04, Jaa03, Syv05]. Commercial arrays are mar-
keted with brands such as: Asper, TaqMan, Sequenom, Illumina, and Affymetrix. The
overall concept of DNA sequence specific hybridisation between a set of reference se-
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quences and the sample sequences is, nevertheless, conserved.
3.1.1 Composition and usage of SNP-microarrays
SNP-microarrays are small chips covered by an array of tiny droplets of short single-
stranded DNA fragments called probes. These fragments of some 25 to 50 nucleotides
are complementary to sequences around the SNP loci. During the hybridisation, some
fragmented and stained sample DNA is put on the array. The single-stranded sample
fragments binds to probes with a complementary sequence. The longer oligonucleotides
are more sensitive and they work with lower DNA concentrations. The shorter sequences
are, however, more specific in binding to their complements. To date, there is no consen-
sus in selecting the optimal length for the oligonucleotides. The protocol used in sample
hybridisation on SNP chip depends on the platform in use but the general concept is to
pour a sample of labelled and fragmented DNA on the chip. The sample fragments are
let to hybridise with the matching complements attached to the chip. The excess sample
material is washed away and the chip surface is ready to be scanned to a bitmap image.
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Figure 3: Size and structure of the XbaI chip. An imagined example of a single probe quartet is
shown on the right. The quartet consists of perfect match and mismatch probes of both alleles. The
distinction between the PM and MM is always made in the middle of the sequence, whereas the
SNP locus varies between the quartets. An example target sequence with a labelling dye residue
has bound to the left most probe, which represents allele C. The other PM probe has not bind to
its target and the sample is considered to be homozygous for the C allele.
SNP-microarrays can be produced in biological laboratories equipped with a microarray
printing facilities. The SNP density of the custom made chips is usually relatively small
comparing to industrial chips but they can be made for such organisms and for such ge-
nomic regions that are not covered by the industrial chips available. The creation of a
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SNP-microarray is a laborious and difficult process not due to challenges to select probes
for the array. The probe selection requires a good knowledge or plausible assumptions
about the genetic variation among individuals so that the SNP loci can be identified and
the whole genome must have been sequenced in order to make sure that the probes are
unique to locus of interest. A single stranded DNA molecule may fold so that it binds to
itself if it contains complementary sequences of its own. The probe selection involves the
verification that there will not be problems with the folding of the molecule. The target
sequence of the probe should be within a range of DNA that can be amplified in order to
establish high DNA concentrations for the hybridisation.
3.1.2 Affymetrix SNP-microarrays
Affymetrix is a company that is specialised in the production of complementary DNA
microarrays. The same photolithography based manufacturing procedure is used for the
production of gene expression and SNP-microarrays, and the physical properties of the
chips are similar. The distinction between these two array types is in the origin of the
sample DNA. The whole genome is used in SNP analysis whereas the expression chips
expect complement DNA of the message RNA molecules restricted from the cells. The
photolithographic synthesis of the probes is done by extending the probes of the selected
spots with one nucleotide at a time [Aff06]. The mount of the chip is first coated with a
light-sensitive chemical that prevents the nucleotides from binding it. The initial coating
is followed by a series of steps.
1. The probes are selected to be extended with a certain nucleotide by using a mask
that allows UV-light to remove their light-sensitive protection.
2. The chip is next flooded with a solution of single nucleotides of one type. Each
nucleotide carries a light-sensitive group protecting it against binding to other nu-
cleotides. The nucleotides are let to bind to the unprotected ends of the selected
probes.
3. The excess of nucleotides is washed away and the process is repeated with another
nucleotide.
Affymetrix provides a wide variety of different microarrays for different purposes and for
different organisms. Genome wide SNP-microarrays for humans are currently available
at resolutions of about 10000 SNPs, 2×50000 SNPs, and 2×250000 SNPs. The combi-
nations of 2 chips work so that the sample DNA is divided into two sets that are digested
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with different restriction enzymes producing fragments based on different splicing se-
quences for PCR amplification. The joint utilisation of the restriction enzymes and the
PCR amplification of the sequences up to 2000 bp allow the reduction the complexity of
the genome by producing copies of regions targeted by the chips [Syv05]. Affymetrix
GeneChip R©Human Mapping 100K Set utilises two chips with restriction enzymes XbaI
and HindIII. Both chips are capable of measuring over 50000 SNP loci consisting of over
2500000 features that is different kinds of probe sequences. Each SNP is targeted with
40 different probe sequences consisting of ten different probe quartets. A probe quartet
consists of a mismatch (MM) and perfect match (PM) probes of both target nucleotides
of the SNP. Perfect match probes match the sequence around the SNP loci and mismatch
probes having a wrong nucleotide in the middle of the probe. The chip architecture as-
sumes that there are only two varying nucleotide candidates for each SNP locus. The use
of MM probes and misclassification of unexpected alleles is discussed in Section 3.2. An
illustration of a fictional probe quartet is given in Figure 3. The exclusive hybridisation
(green sample fragment with a fluorescent biotin label) of the left most perfect match
probe indicates homozygosity for C allele (no hybridisation to other PM probe) and good
separation between the probes (no cross hybridisation to MM probes).
3.2 Data preprocessing
The data processing starts from the scanned image the first step being the detection of
the hybridisation spots and their intensities. The sequence fragments from the sample
can be detected as fluorescent spots on the array since they carried the labelling dye to
their hybridisation position. The exact sequence is known as the underlying complement
sequence. The intensity of the spot tells us about the abundance of the sequence indicating
whether the sequence is present or not. Comparing the abundance information between
consecutive SNPs and the values of a control sample with a known copy number gives an
opportunity to estimate the chromosomal copy number [Nan05, Tin06, Zha04, Zha05].
Preprocessing of the SNP-microarray data covers the process of detecting haplotypes of
individuals from the bitmap image produced by the scanner. The standard preprocessing
process consists of five major steps: grid detection, intensity calculations of the spots,
quality diagnostics, normalization, and estimation of the haplotypes.
Grid detection involves the recognition of the array of rows and columns of different
oligonucleotides. The fitted grid is usually an array of rectangles with a certain amount
of tolerance for irregularities of the array and the produced image.
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Intensities of the spots are the actual information provided by a SNP-microarray experi-
ment. Determination of the intensity is a nontrivial task subjected to various sources of
errors such as irregularities of the shape of the spot, spatial variation in scanner sensitivity,
levels of hybridisation, and unexpected intensity distribution within a grid bounded area.
The intensities of the spot should be of the same scale if they are to be compared against
each other. The process of the value scaling and shifting is called normalization. One
of the major reasons for the normalization is to reduce the non-biological variation that
is noise in data. A typical SNP-microarray contains various spots that measure the same
region of the genome and it is assumed that their values should correlate in a manner that
depends on their relation to the SNP, which is usually same value for the probes of the
same allele. The assumption behind normalization is that the overall distribution of the
intensities is known and the measurements follow it.
The purpose of the mismatch probes of Affymetrix GeneChip R©Human Mapping chips
is to measure the level of non-specific hybridisation that is considered to be the back-
ground intensity. The intensities of the PMs are determined based on their difference in
corresponding MM intensities. The constitution of alleles in each SNP can be determined
using the dynamic modelling (DM) algorithm that compares the likelihoods of models of
aa, ab, bb, and NoCall [Di05]. The algorithm makes no clear distinction between ho-
mozygous and hemizygous loci and the most likely model is used as a genotype estimate.
The determination of the SNP alleles is made in a SNP and chip specific manner. The
genotype estimates of the multi-chip studies may use the robust linear model with Ma-
halanobis distance classifier (RLMM) that utilises the information about the similarities
between the probes and genotypes of different chips [RS05].
There are various causes for missing values in SNP genotypes [Car06]. The undetected
alleles can be seen as NoCall values or hemizygous SNPs depending on whether they
occur in one or both homologous chromosomes. Some of these undetected, so called null
alleles can be caused by a deletion [Con06]. The deletions can be of biological origin
but they may also indicate sample degradation or other difficulties in the SNP experiment.
The samples with high rates (>0.05k) of NoCall SNPs are likely to be degraded or the
experiment has failed [Aff04]. Some of the null alleles can be explained by another poly-
morphism so close to the SNP site that it interferes with the probes and there is also a
chance of having more than two alleles within the population. Affymetrix arrays are built
so that they are targeting only two known allele polymorphism but the structure of DNA
allows total of 4 (adenine, thymine, cytosine and guanine) different nucleotides for each
locus.
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4 Analysis Methods for Homozygous Regions
Detection of homozygous regions from the normal tissue of distantly related samples is
one of the most important goals in this study. A homozygous region is a chromosomal
region with the same allele inherited from both parents. The aspects of this definition will
be further discussed in Section 4.1. Section 4.2 describes algorithms that can be used to
detect homozygous regions from SNP-microarray data. The sample-wise comparison of
the regions is discussed in Sections 4.3 and 4.4, which describe the concepts of interesting
region, region score and compound heterozygotes.
4.1 Definition of the homozygous region
The concept of a homozygous region refers to a genomic subsequence containing a con-
tinuum of homozygous loci. The consecutive SNP samples from such region should be
homozygous and we can assume that a sequence of such homozygous SNPs contains
homozygous nucleotides between the SNP loci. The exact base pair bounds of the ho-
mozygous regions cannot be given using plain SNP data as it gives no information about
the nucleotides between the bounding homozygous and heterozygous SNPs. Here, we
extend homozygous regions all the way to the next heterozygous SNP loci, which mean
that we may have coupled some heterozygous nucleotides into consideration but at least
we do not miss the homozygous ones.
Let there be n samples each consisting of k SNP loci. A trivial way of defining a homozy-
gous regions matrix R ∈ {0, 1}n×k for the samples S ∈ {aa, ab, bb}n×k is to create a Boolean
function indicating the homozygous loci of each sample as
Rr,c =

1, Sr,c = aa
∨Sr,c = bb
0, Sr,c = ab
, r ∈ [1, n], c ∈ [1, k]. (1)
Now the Boolean matrix R contains series of ones representing the homozygous regions.
Too short regions can be filtered out by selecting sequences of at least l ones in a row.
Another way of saying this is that homozygous SNP at Rr,c is surrounded by l − 1 other
homozygous SNPs. Table 1 illustrates how we can calculate homozygous SNPs around
the given (r, c) in all possible l ways. Rr,c belongs to a long enough sequence if and only
if the sum of any of these counts becomes l. A formal representation for the length limit
can be written as:
Rlr,c =
c∨
v=c−l+1
(( min(v+l,k)∑
i=max(v,1)
Rr,i
)
= l
)
, l ∈ [1, k]. (2)
16
A) c k
Rr . . . 0 0 1 0 1 1 1
∑ l
———— 2 ,4 → 0
———— 3 ,4 → 0
———— 3 ,4 → 0
——— 3 ,4 → 0
Rlr . . . 0 0 0 0 0 0 0
B) c k
Rr . . . 0 0 1 1 1 1 0
∑ l
———— 3 ,4 → 0
———— 4 =4 → 1
———— 3 ,4 → 0
——— 2 ,4 → 0
Rlr . . . 0 0 1 1 1 1 0
Table 1: Illustration of the Equation 2. SNP (r, c) is part of a sequence of length 3 in case A and
the Rlr,c is 0 because l = 4. Case B shows how one of the summations becomes 4 leading to the
recognition of the sequence.
The idea in Equation 2 is to test all possible l length sequences containing Rr,c. The
disjunction is satisfied if there is at least one sequence without a heterozygous gap. Index
i is kept within [1,k] by using the min and max functions.
A difficulty in defining the concept of homozygous region arises when there are inaccu-
racies in the data and we may see some heterozygous SNPs in otherwise homozygous
region. There are many different possibilities to handle the noise in data but the approach,
that is chosen affects to results and thus it is important to understand the behaviour of the
approach in use. All methods must favour regions with a higher rate of homozygous SNPs
for homozygous regions and reject regions with a too low density in order to be useful.
A simple step towards non-uniform regions is to define the minimal distance d between
any two gaps within a region. Each gap of heterozygous SNPs must be shorter than s. The
formal definition of this gap distance model can be derived in two steps using Equation
2. First, a matrix Rgd′ of homozygous fragments of at least d continuous SNPs is created:
Rgd′r,c =
c∨
v=c−d+1
(( min(v+d,k)∑
i=max(v,1)
Rr,i
)
= d
)
, d ∈ [1, l]. (3)
Second, those fragments in Rgd′ that are separated by s or less SNPs are merged. The
conjoining of the fragments and the application of the length limit l can be coupled into
form of:
Rgdr,c =
c+l−1∨
j=c
( j+s−2∧
v= j−l−s+1
(( min(v+s,k)∑
i=max(v,1)
Rr,i
)
≥ 1
))
. (4)
The length of a gap is less than s if the sum exceeds 1 in all windows of s + 1 columns
that contain columns of the gap. An example illustration of the steps involved in the
calculation of Equation 4 is given in Figure 4.
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Figure 4: Visualisation of Equation 4 with parameters l = 6 and s = 2. An example sequence
of Rgd
′
r is given at the top and the positions of c and the bounds of the left and right most l long
regions are marked above it. Each row of s+ 1 long green and red lines represents the sums of the
conjunction. Green lines represent cases where the sum ≥ 1 and the false cases are shown in red.
The value of the conjunction is given on the left and the outer disjunction is true if any of these
values is true.
Gap distance method can be implemented efficiently (the algorithm is given in Section
4.2) and it gives unambiguous results in both direction along the sequence. The distance
parameter d, however, is extremely sensitive to uneven distribution of heterozygous SNPs
making it quite hard to increase the parameter value. We improved the method by replac-
ing the distance parameter with a sliding window that calculates the rate of heterozygosity
around the SNPs.
Sliding window can be used to measure the level of local homozygosity at a particular
subsequence. Sliding window is less sensitive to intermediate distances of genotyping
errors in comparison to gap distance method. Let w be the length of the window and g the
maximal heterozygosity rate and we can formulate matrix Rsw′ as
Rsw′r,c =
(∑min(c+w/2−1,k)
i=max(c−w/2,1) Rr,i
w
≥ 1 − g
)∨
Rr,c, w ∈ [1, k], 0 ≤ g ≤ 1. (5)
Equation 5 gives us regions with lengths anything between 1 and k but too short regions
can be filtered using the Equation 2:
Rswr,c =
c∨
v=c−l+1
(( min(v+l,k)∑
i=max(v,1)
Rsw′r,i
)
= l
)
. (6)
The last expression extends each region with the surrounding homozygous SNPs.
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4.2 Detection Algorithms
Selection of the proper searching algorithm depends on the definition of the homozygous
region. Some possible definitions were discussed in Section 4.1. The following three
different methods have been implemented in CohortComparator: gap distance, gap ratio,
and sliding window. All algorithms are quite similar in their structure and thus the same
base algorithm can be adapted to all of them.
findHomozygousRegions(snps, l, s, d)1
regions ← ∅2
pS ← −1 : Start position of the region3
pE ← −1 : End position of the region4
gc ← 0 : Gap length counter5
rc ← 0 : Region length since the last gap6
for (col in snps) {7
if (snpscol = NA) next8
if (snpscol , ab) {9
if (pS < 0) pS ← col10
rc ← rc + 111
gc ← 012
if (SNP_CODE) pE ← col13
} else {14
if (pS > 0) {15
gc ← gc + 116
if ((gc > s) ∨ REGION_CODE) {17
if ((pE > 0) ∧ (pE − pS + 1 ≥ l))18
regions ← regions ∪ (pS , pE)19
pS ← −120
}21
}22
rc ← 023
}24
}25
if ((pS > 0) ∧ (pE > 0) ∧ (pE − pS + 1 ≥ l))26
regions ← regions ∪ (pS , pE)27
return(regions)28
Figure 5: Template code for the recognition of homozygous regions. Blue parts of the code rep-
resent an example implementation of gap distance method. The implementations of the statements
SNP_CODE and REGION_CODE vary in different region recognition algorithms. Gap distance
method defines these statements as: SNP_CODE =(rc ≥ d) and REGION_CODE =(rc < d).
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Template of the generic region recognition algorithm is given in Figure 5. The region
recognition function findHomozygousRegions() takes three parameters: a sequence
of SNP genotypes (snps) of one sample, the minimum length of the region (l), and the
maximum length of a continuous gap (s). A set of region start and end SNP pairs is pro-
duced for the given sequence. Method specific implementations of the algorithm vary
in SNP_CODE and REGION_CODE statements and they have some additional book-
keeping variables in order to meet the requirements of these two Boolean statements.
SNP_CODE is a Boolean statement that is true if and only if the homozygous SNP snpscol
can be accepted into a region. REGION_CODE is another Boolean statement, which is
true if and only if the gap tolerance limits are exceeded by the heterozygous SNP snpscol.
Gap distance method is based on Equations 3 and 4. The algorithm keeps count of
how many homozygous SNPs there has been since the last heterozygous SNP (rc) and
SNP_CODE is a simple comparison whether rc ≥ d. REGION_CODE can be given as a
complement of SNP_CODE (rc < d).
Gap ratio method accepts heterozygous SNPs as long as the rate of heterozygosity is kept
below the threshold g, where the parameter g is defined as a ratio of heterozygous SNPs
since the opening of the region (pS in Figure 5) and the total amount of SNPs within that
range is counted in gt. The parameter gt is incremented together with gc but reset to 0
along with pS . The generic template algorithm can be adjusted to the gap ratio method by
replacing SNP_CODE with a check that gt/(col − pS + 1) ≤ g. The same expression can
be used in REGION_CODE except that "≤" operator has to be replaced with ">" operator.
The advantage of gap ratio method is that it is more flexible than the gap distance method
in terms of variation in distances between the gaps and it is easier to determine an ac-
ceptable rate of heterozygosity than a distance limit. However, the gap ratio method has
some major weaknesses. First, long homozygous regions are joined together although
they have a significant amount of heterozygosity in between suggesting several separate
regions. Secondly, long regions have a tendency of getting a tail of miscellaneous short
repeats of homozygous SNPs. Thirdly, regions are interrupted by gaps in the beginning of
the region. These drawbacks can be tackled by a sliding window that is used to determine
the local gap density surrounding each SNP.
Sliding window method is the most complex of three homozygosity search methods used
in CohortComparator. The implementation follows the concept of Equation 5 and the
method has the advantages of the direction insensitivity and robustness against uneven
distance between the genotyping errors. The generic template algorithm can be used for
the sliding window by replacing SNP_CODE with a constant TRUE corresponding to the
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disjunction of Rr,c in Equation 5. REGION_CODE is responsible for the left side of the
disjunction where the ratio of heterozygous SNPs is calculated within the window and
tested against the g.
locus: 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20
Sample 1: aa aa aa aa aa aa aa aa aa aa aa aa ab aa ab aa ab aa aa aa
gap distance — — — — — — — — — — — — — — — — —
gap ratio L — — — — — — — — — — — — — — — — — — — —
gap ratio R — — — — — — — — — — — — — — —
sliding window — — — — — — — — — — — — — — —
Sample 2: aa aa ab aa aa ab aa aa aa ab aa aa aa aa aa aa aa aa aa aa
gap distance — — — — — — — — — — — — — —
gap ratio L — — — — — — — — — — — — —
gap ratio R — — — — — — — — — — — — — — — — — — — —
sliding window — — — — — — — — — — — — — —
Table 2: A comparison of regions detected by different gap models. The parameters of the models
are: l=3, d=3, g=0.2, and w=10. Homozygous regions are labelled with “—” and heterozygous
regions are shown as blank.
Some of the differences between the methods of detecting homozygous regions are illus-
trated in Table 2. Gap ratio method is listed twice as its behaviour is direction dependent.
Gap ratio versions L and R refer to iteration from left to right and vice versa, respectively.
It can be seen that the gap ratio method is very sensitive to the gaps in the beginning of the
homozygous region (Sample 2: locus 10) but tolerates many gaps after long homozygous
regions (L: Sample 1, R: Sample 2). The context specific sensitivity of the sliding window
is demonstrated in the recognition of the gap dense region at locus 13 of Sample 1, which
is ignored by gap distance method. The locus 10 of Sample 2 is considered homozygous
by both methods as it is surrounded by a continuum of homozygous loci.
It is worth of notice that gap distance, gap ratio, and sliding window all ignore the dis-
tances between the SNPs and assume a uniform distribution over each chromosome. The
actual distribution of SNPs in contemporary microarrays is quite far from being uniform
and the behaviour of the algorithm may vary in different parts of the chromosome [Nic06].
Reason for the variation is that all distances are measured in numbers of SNPs and thus
the meaning of parameter values depends on the local SNP density. The compensa-
tion of non-uniform distributions has been implemented by providing an option to use
base pair distances in parameters l and w. The implementation of this option required
an additional input array defining the SNP loci and the distance calculations between
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pS , pE were conducted using the array values of corresponding indices. The bounds of
the sliding window are calculated by searching the outer most SNPs within the range of
[col − w/s, col + w/2 + 1].
Hidden Markov models are widely used statistical models for detecting sequence types
in bioinformatics. The models consist of states, transition probabilities between the
states and emission probabilities for having a certain value in each state. The distinc-
tion between homozygous and heterozygous regions could be modelled in various ways.
In the simplest case there would be two states Xhomozygous and Xheterozygous, transitions
A1 = Xhomozygous→Xhomozygous, A2 = Xhomozygous→Xheterozygous, A3 = Xheterozygous→Xhomozygous,
A4 = Xheterozygous→Xheterozygous, and the emission probabilities of getting a homozygous or
heterozygous SNP for both states. Even the simplest HMM contains two transition proba-
bilities and four emission probabilities that should be estimated somehow. The estimation
of these parameters could be done using Baum-Welch algorithm [Bau70] in case there
are samples with known homozygous and heterozygous regions but the information is not
available as the labelling of the regions depends on the definition of homozygous region
itself.
The HMM models tend to produce ambiguous bounding for the homozygous regions de-
pending on the iteration direction along the SNP sequence. The ambiguities are caused
by Viterbi algorithm [Vit67] that is used to find the most probable sequence of states
for the observed sequence of emitted values (SNP genotypes). The algorithm keeps list
of probabilities of possible state sequences during the iteration of the genotypes and se-
lects the most likely transition based on the transition probability and the probability of
emitting the observed value in that state. Emission probabilities of homozygous SNPs in
Xheterozygous and heterozygous SNPs in Xhomozygous represent the rate of genotyping errors
[Ber06]. Transitions between homozygous and heterozygous regions (A2, A3) are less
probable than those between the states (A1, A2). The differences between the results of
the different iteration directions depends on how many false emissions can be accepted
before it becomes more likely that the emissions are true but the underlying state has
changed.
The HMMs have been used for the detection of LOHs in comparison of “normal” and
tumour samples [Lin04] and plain tumour samples [Ber06]. Beroukhim et al. [Ber06]
compared their HMM against a simpler model that they called NumHom. NumHom is
essentially what is captured by Rl and it was shown to be less specific than the HMM.
The lower specificity was caused by the stretches of homozygous SNPs in linkage dise-
quilibrium; the stretches that were are trying to capture in this study.
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4.3 Scoring
The genome wide analysis of a genotype data set may give more than thousand possibly
interesting regions depending on the parameters and number of samples. The complete
analysis of all these regions for all associated samples would take far too much time and
resources. Clearly, a scoring scheme is required for the set of possibly interesting regions.
The scores can be calculated only if there is a metric that tells, which are the most promis-
ing candidates for the wet lab analysis. Qualities of the regions can be described in terms
of the length, relative frequency of its features between the controls and the patient sam-
ples [Woo04], and its biological content. In this section we concentrate on the first two
properties also used in CohortComparator. The last and perhaps the most important
property is discussed in Section 5, where we look at the annotations.
A possibly interesting region consists of samples with homozygous alleles overlapping
the region loci. The region consists of alleles that are not homozygous in reference sam-
ples. The type of the interesting region depends on the number of alleles that it covers.
An interesting region may represent a feature of general homozygosity if there are not
too many overlapping homozygous regions in references. Interesting regions may repre-
sent allele specific features if they have an allele that is not homozygous in references but
the references are homozygous for some other alleles. An interesting region may cover
the whole length of a homozygous region in one sample but another sample may share a
fraction as well. The scoring of the region should be based on the length of the features
and thus we are not calculating the actual length of the region itself but the total length
of sample features overlapping it. CohortComparator implements two different meth-
ods for this: total includes the length of the whole feature even if a part of it overlaps
with the region; fraction takes only the intersection of the feature and the region into
account. The difference between these two methods is visualised in Figure 6, in which
two interesting regions A1 and A2. The features are required from two or more samples
in this example and they must not be present in the reference. A1 consists of blue alleles
present in homozygous regions r3, r4, and r8. A2 represents the homozygosity of ho-
mozygous regions r5, r7, and r9. Parts of the homozygous regions that are used in the
scoring methods, total and fraction, have been marked with yellow and green lines,
respectively.
Both scoring schemes have been tested in genome wide analysis with the same parame-
ters and the fraction method agrees better with the manual scoring given by a biologist.
Long homozygous regions dominate the results of the total method even if the interest-
ing region is very short and shared by few individuals.
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Figure 6: Example pattern of homozygous regions.
Score values are most useful as sorting criteria. The interpretation of the meaningful-
ness of the value itself is quite hard since the range of possible scores is [0, k]. Getting
the score of k would mean that all SNPs would differ in all samples between the data
sets. The analysis of the score distributions revealed an interesting fact that a function
of score(regionNumber) = a/regionNumber fitted extremely well to observed values.
Parameter regionNumber is the index of the interesting region within a sorted list of
scores, whereas a refers to a scaling factor that is calculated by minimizing the function∑
|scorei − (a/i)|. Visual comparison of the scores and the function is given in Figure 7.
The estimation function a/regionNumber of the scores is monotonically decreasing but
non-linear within [1, max(x)]. One possible way of determining meaningful scores is to
calculate the point of the curve after which the decrease is too slow that is the second
derivative of the curve is greater than a given limit. Another method for the estimation of
saturation point of the scores is to take an advantage of the symmetry of the 1/x function.
The score density (y-axis) is higher than the region sample density (x-axis), when the
scores are below the intersection of the symmetry axis if both axes are scaled to the same
range, say [0, 1]. The meaningfulness of the score values is greater in regions exceeding
the limit whereas other consecutive (based on their scores, not physical locations) regions
have little or none difference in their scores. The scaling factor for the axis is estimated
as max(score)/count(regions).
4.4 Compound heterozygosity
Regions of compound heterozygosity contain two different mutant alleles at the same lo-
cus. Individuals with compound heterozygote regions may express recessive phenotypes
if both alleles have the same or similarly behaving mutation. Compound heterozygotes
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Figure 7: Score distributions of fraction and total methods. Vertical bar on the left contains
a black line if there are interesting regions with the corresponding score giving a broad overview
of score densities. Exact scores are plotted in descending order so that x-axis represents the in-
dex of each region within the list. The best fit of the red a/x curve and its intersection with
(max(score)×x)/count(regions) is used to estimate the saturation point of scores. Left diagram is
created using fraction scores and the right one is based on total scores. Scores of the figure
are from the genome wide analysis with parameters: l.limit.d = 55, l.limit.r = 25, sliding window
(w = 20, d = 0.05), f .limit.d = 0.03, f .limit.r = 0.
can be affected with recessive disorders although their parents are not related [MYE98].
Regions of potential compound heterozygosity for alleles in R can be defined as:
Cr,c =

1,
∨n
s=1
((Sr,c = ab∨ Sr,c = Ss,c ∨ Ss,c = ab)∧(Rs,c = 1))
0, ∨ns=1 ((Sr,c = aa∧ Ss,c = bb)∨(Sr,c = bb∧ Ss,c = aa)∨(Rs,c = 0)), (7)
where r ∈ [1, n]−s. The matrix C contains 1 for each SNP that may be a combination of an
allele in any overlapping homozygous region in R. The definition as such is obviously too
weak since a huge amount of short sequences is generated simply by chance. A simple
and consistent method to increase the reliability of the regions is to set the minimum
length (l) for the region of interest as was done with the homozygous regions in Equation
2. The replacement of the homozygosity matrix R with C gives us a more informative
matrix:
CFr,c =
c∨
v=c−l+1
(( min(v+l,k)∑
i=max(v,1)
Cr,i
)
= l
)
, l ∈ [1, k]. (8)
The construction of the matrix CF in Equation 8 does not take SNPs into account if they
are not part of a homozygous region and it assumes that each homozygous region is a
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continuous haplotype. The content of a homozygous region is, however, a sequence of
haplotypes that might have a different origin. Pieces of different pre-existing haplotypes
may be found from a single homozygous region and thus another individual may be com-
pound heterozygote for parts of the region sharing some of the original haplotypes. A
long homozygous region compared against another sequence, where the length of the se-
quence is much less than l, gives us those partial compounds that are not too close to the
ends of the homozygous regions. The detection of compound heterozygotes at the ends
would require a check for l − 1 SNPs before and after the region. Problem with these
SNPs is that we do not know the chromosome specific sequences as the SNPs may be het-
erozygous. The use of heterozygous SNPs would require information about actual DNA
strands responsible for the SNP alleles in order to create sequences for the compound
search.
An estimation of the DNA strands can be done by calculating an estimate of the haplo-
types of the sample population (see fastPHASE in Section 6.2). Compound heterozygotes
can be determined to any chromosomal region if the haplotypes of all samples are known.
Compound heterozygotes can be found by checking whether a sample contains the mutant
alleles at the given locus. An important difference to the method of detecting potential
sites of compound heterozygosity described above is that both strands can be compared
in full length. Possibly interesting alleles can be found although they are not homozy-
gous in any of the samples but if they are seen in compound heterozygotes together with
an allele that has been homozygous but such allele combinations are absent in reference
set. Chances are that both allele contain a similarly behaving mutation and thus express
a recessive phenotype (=developed a cancer). The use of haplotype data in the search
of compound homozygotes is out of the scope of this study and will be incorporated to
forthcoming releases of CohortComparator.
The algorithm used for the recognition of the potential compound heterozygotes is almost
identical to that used in the recognition of homozygous regions (see Figure 5). The only
exception is that snpscol is not compared against ab (line 8) but against the given homozy-
gous region (comp) that is supposed to match the other component of the compound. The
comparison expression is (compcol = NA) ∨ (compcol = snpscol) ∨ (ab = snpscol) ∨ (ab =
compcol). The only purpose of the statement ab = compcol is to allow both alleles where
a gap was found in the original homozygous region. The homozygous regions can be
represented as haplotypes of two identical strands of homozygous alleles. The haplotype
representation of the homozygous region would lead to a theoretically more sophisticated
formulation in a sense that it is a haplotype that is searched for but the results would
remain the same. The haplotype representation of a homozygous region would contain
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missing values (NA) in places of heterozygous SNPs and the comparison would be given
as (compcol = NA) ∨ (ab = snpscol) ∨ ((compcol = a) ∧ (snpscol = aa)) ∨ ((compcol =
b) ∧ (snpscol = bb)). In this context, the use of haplotype representation is not computa-
tionally feasible since the allele combinations are readily available in matrix S.
Parameters of the algorithm are chosen so that each violation of the given expression ter-
minates the region. A region cannot be considered as a possible compound heterozygote
only if there is a homozygous SNP with a complementary allele. The probability of hav-
ing l SNPs without such alleles is already so high that false positives can be expected but
the addition of gaps into this model would increase their number even more. The gap dis-
tance method with d = l is used since it the fastest algorithm. An additional optimisation
is done concerning the last l− 1 SNPs. There is no need to check last SNPs if pE < 0 and
the loop can be terminated. The same trick could be used in the search of homozygous
regions but the code has been coupled with the detection of deletions that can be found
from the tail of the sequence.
Equation 7 defines all regions that are possible compounds of any homozygous region in
R but the number of regions can be significantly decreased if the matrix is constructed so
that it includes only those regions of the cancer patients that overlap with an interesting
region they belong to. The final results are clipped to the interesting areas as the result
of such limited search consists of compound heterozygotes that are closely around the
interesting regions but the exact bounds depends on the length of those areas of the ho-
mozygous regions that are outside of the interesting region. All interesting areas with their
homozygous regions are analysed in the order of their loci, which means that the same
homozygous region would be analysed several times if it belongs to several interesting ar-
eas. Comparing this region against the others would not be feasible if that has been done
already and thus a list of end loci of samples is kept. The end position of the homozygous
region is compared against this list each time a homozygous region is selected from an
interesting region. The actual search takes place only if the value associated to the sample
is less than the new value and the sample value gets updated.
The interesting regions that contain no compound heterozygotes are of the special interest
since that is a sign that the alleles of the patient regions are especially rare within the
population. CohortComparator reports all such regions in its output and the regions are
emphasized in its graphs (see Appendix 1). The current version of CohortComparator
does not report compound free regions with reference compounds to one or more ho-
mozygous allele, although there would be other alleles that do not have compound pairs
in references.
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5 Annotations
The list of interesting homozygous regions consists of sequence combinations that are rare
in references. However, it contains no information about biological effects caused by this
variation. Further, the scoring scheme cannot be used to distinguish cancer related regions
from other homozygous regions. The biological significance of a genomic region depends
on its cellular function in terms of transcripts, protein binding affinities and folding (3-
dimensional structure) properties. A mutation in a critical part of the DNA may lead to
significant changes in individual’s phenotype; a gene may get inactivated, for instance.
The chance of developing a cancer increases if a tumour suppressor gene gets inactivated
in both chromosomes. It is not know, which genes are tumour suppressors, as we are
trying to find new ones. Locations of the most genes are, however, known. Information
about the genes can be assigned to interesting homozygous regions and it can be assumed
that some of the genes may be involved in the development of cancer. On the other
hand, a region is less likely to be worth a wet lab investigation if it does not have a gene
association. A high number of genes found to overlap with a region does not necessarily
make the region more interesting since an interesting mutation may affect just one gene.
The attention can be focused on regions with cancer associated genes but one must keep
in mind that almost all genes are somehow associated to cancer and the interpretation of
the relationship may be hard to do in an automate manner.
The biological content of the interesting regions is retrieved from Ensembl genome database
[Bir06], which contains DNA sequence and gene information of various animals. The
database version used in this study covers 21571 known human genes, 2142 novel genes
waiting for confirmations and a variety of RNA transcripts. The database content is main-
tained in regular basis as the biological knowledge alters and the content is publicly avail-
able for direct database queries and database exports that can be copied to the local repli-
cates. Ensembl database describes each transcript with a variety of properties such as:
1. a common name for the gene,
2. the chromosome location,
3. a list of exons and their locations,
4. type of the gene discriminates between the protein coding genes and various types
of RNAs,
5. a list of transcripts and splice variants encoded by the gene,
6. status of the confidence that tells whether the gene is well known or predicted by
bioinformatical software for example,
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7. a short description of its biological function,
8. references to microarrays targeting the gene, and
9. database identifiers for other databases.
The list possibly interesting chromosomal regions is compared against Ensembl database
and a list of overlapping genes is associated to each region. An example list or genes
associated to interesting regions is shown in Table 3. The list can be used for several
important purposes. First, the lengths of the genes and the exon counts can be used
to estimate how much work is needed to sequence the possible mutations. Second, the
microarray probe identifiers help in comparing the gene list against the gene expression
studies if such information is available. Third, the list of possibly affected genes can be
compared against other databases describing other interesting aspects of genes.
.
.
.
- 4: 88155377-88277512 (5816)
4: 88075187-88281214 AFF1 (KNOWN): protein_coding, AF4/FMR2 family member 1 (Protein AF-4) (Proto-oncogene AF4) (Protein FEL).
[Source:Uniprot/SWISSPROT;Acc:P51825], 24 exon(s), probes: [U133_X3P:214448_3p_x_at:1109:501;] IDs: [acces-
sion=ENSG00000172493]
- 3: 161313644-161435642 (5809)
3: 161426323-161428693 Q8N5S4_HUMAN (KNOWN): protein_coding, 1 exon(s), probes: [U133_X3P:201555_3p_at:1140:647;] IDs: [acces-
sion=ENSG00000180044]
3: 161427938-161650320 TRIM59 (KNOWN): protein_coding, Intraflagellar transport 80 homolog (WD repeat protein 56).
[Source:Uniprot/SWISSPROT;Acc:Q9P2H3], 28 exon(s), probes: [U133_X3P:Hs2.105633.2.S1_3p_a:649:1141;] IDs: [acces-
sion=ENSG00000068885]
- 6: 49771426-49852590 (5797)
6: 49768032-49789258 CRISP2 (KNOWN): protein_coding, Cysteine-rich secretory protein 2 precursor (CRISP-2) (Testis-specific protein TPX-1).
[Source:Uniprot/SWISSPROT;Acc:P16562], 14 exon(s), probes: [HG_U95Av2:34480_at:61:247;] IDs: [accession=ENSG00000124490]
6: 49803056-49820040 CRISP3 (KNOWN): protein_coding, Cysteine-rich secretory protein 3 precursor (CRISP-3) (SGP28 protein).
[Source:Uniprot/SWISSPROT;Acc:P54108], 11 exon(s), probes: [HG_U95E:70801_at:370:17;] IDs: [accession=ENSG00000096006]
- 15: 46920822-47004014 (5768)
15: 46903227-47042933 SHC4 (KNOWN): protein_coding, rai-like protein [Source:RefSeq_peptide;Acc:NP_976224], 12 exon(s), probes:
[HG_U95E:76135_at:608:285;] IDs: [accession=ENSG00000185634]
15: 46957582-46959672 NM_014335.2 (KNOWN): pseudogene, CREBBP/EP300 inhibitor 1 (CRI1), mRNA [Source:RefSeq_dna;Acc:NM_014335], 2 exon(s),
probes: [HG_U95B:52746_at:434:143;] IDs: [accession=ENSG00000178558]
- 2: 80998358-81118937 (5742)
- 8: 78328040-78448532 (5738)
- 1: 105812910-105933049 (5721)
- 8: 14623177-14743200 (5715)
8: 13991744-15140219 SGCZ (KNOWN): protein_coding, Zeta-sarcoglycan (Zeta-SG) (ZSG1). [Source:Uniprot/SWISSPROT;Acc:Q96LD1], 10 exon(s), probes:
[U133_X3P:Hs.123349.0.A1_3p_at:487:1009;] IDs: [accession=ENSG00000185053]
- 3: 163227593-163287964 (5715)
- 13: 48209948-48329829 (5709)
13: 48237029-48237137 5S_rRNA (NOVEL): rRNA, 5S ribosomal RNA [Source:RFAM;Acc:RF00001], 1 exon(s), probes: [HG_U95Av2:378_s_at:392:491;
HC_G110:378_s_at:246:263;] IDs: [accession=ENSG00000199376]
.
.
.
Table 3: Annotation list of interesting regions Interesting regions are listed in the descending
order based on their scores. Each region starts with a hyphen followed by its genomic location
given in a form of chromosome number and the range of base pairs. The location information is
followed by the score, which is given in parenthesis. The biological content of the region is given
in below each region so that each transcript is listed in its own line starting with the associated
chromosome location. The name of the transcript is followed by its status and biological type. A
short description of the gene is given before an exon count and the lists of associated microarray
probes and database identifiers.
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Gene Ontology (GO) [Ash00] is a database that consists of terms representing biological
concepts such as ’apoptosis’ and ’response to virus’. The terms have been organised into
a directed acyclic network that describes their relationships so that the terms are bind to
their more generic parents. For example ’apoptosis’ is a child of ’programmed cell death’,
which in turn is a child of ’cell death’ and so on. RegionAnnotator provides a query tool
that can be used to select interesting regions based on a GO term. The program takes
RegionAnnotator output files as its input and compares all GO.
SNPs3D database [YMM06] can be queried for disease associated genes. Disease Can-
didate Gene module of the database provides an interface to a text mining tool. The tool
can be used to extract gene names based on keywords that are used in the abstracts of
articles available in Medline. The set of keywords is constructed by selecting abstracts
with the name of the disease. The words of these disease related abstracts are compared
against all abstracts to filter out common words that are not related to disease. The 40
terms that are the most restricted to the scope of the disease are used as keywords. For
example the set of colorectal cancer keywords suggested by SNPs3D site consists of such
words as:“colorectal cancer”, “hnpcc”, “crc”, “colorectal”, “nonpolyposis colorec-
tal”, “hereditary nonpolyposis”, “nonpolyposis”, “cancer hnpcc”, “msh2”, “colorec-
tal neoplasms”, “colorectal neoplasms, hereditary nonpolyposis”, “colorectal cancers”,
“hmsh2”, “mlh1”, “hmlh1”, “msi”, “sporadic colorectal”, “mmr genes”, “cancer crc”,
“colorectal cancer patients”, “human colorectal”, “non-polyposis colorectal”, “heredi-
tary non-polyposis”, “non-polyposis”, “amsterdam”, “colorectal cancer cells”, “mmr”,
“msh2 protein, mammalian”, “mlh1 protein, mammalian”, “microsatellite instability”,
“colorectal cancer cell lines”, “primary colorectal”, “amsterdam criteria”, “hereditary
nonpolyposis colorectal cancer”, “mismatch repair”, “hereditary nonpolyposis colorec-
tal cancer hnpcc”, “dna mismatch”, “hnpcc patients”, “repair mmr”, and “instability
msi“. SNPs3D retrieves the gene names from NCBI Gene database and compares them
against the disease articles. The genes that are mentioned in articles are returned with an
association score indicting how well the keywords and the gene name matched the ab-
stracts. The list of genes received from SNPs3D database can be compared against the
region annotations of RegionAnnotator.
Interesting lists of genes can be found not only from the databases but also from some
articles. For example, an extensive study of colorectal and breast cancers was explained
in [Sjö06]. The supplement lists of mutated genes in colorectal cancers provided a source
of potential genes that may have affected in the development of the cancer.
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6 Materials and Methods
The cause of the CRC is likely to vary between the patients and we expect to see only few
individuals sharing a common recessive mutation [Aal]. The practical consequence is that
we must be able to detect 2–5 positive hits out of some tens of obtained candidates mak-
ing the signal far too weak for standard statistical tests between the patient and reference
samples. The problem can be seen when the allele distributions are compared between
the sample groups and false discovery rate correction [PC06] filters out all possibly in-
teresting loci (see Section 7). Long continuous homozygous regions have been used to
identify regions that are likely to be autozygous.
6.1 Origin of the data
Samples of the colorectal cancer patients (SD) were all from Finland. Total of 50 un-
related patients have been selected out of 1044 colorectal cases (the original collection
of colorectal cancer patients is described in [Aal98, Sal00]). The cause of the cancer in
these 50 patients was not explained by known reasons and they had at least one sibling
with a colorectal cancer, which suggests a recessively inherited mutation. The parents of
the patients were both healthy. The samples with a known cause (microsatellite instability
caused by a mutation in mismatch repair genes such as MLH1, MSH2, MYH and MYH11)
were excluded as we are trying to detect new tumour suppressor genes.
DNA was extracted from the frozen tissue samples of the selected 50 patients were sent
out to a lab 4 in the US for the hybridisation. The microarray experiments were carried
over using Affymetrix GeneChip R©Human Mapping 100K Set and the standard protocol
[Aff04]. The chips were scanned and the raw data was sent back to us in Affymetrix .CEL,
.CPH, and .EXP files.
Samples with more than 0.05k NoCall SNPs were considered unsuccessful since they
would have too many false positives in homozygosity analysis. Unsuccessful cases were
left out of studies leaving 42 sets of data for the analysis. The sample material was not
collected from tumours but the surrounding healthy tissue and thus we are not analysing
colorectal cancer genomes but genetic background of those subjected to it.
Reference samples (SR) were of the miscellaneous origin but they all were analysed using
only one (XbaI) of the two microarrays. The consequences of the lower SNP resolution,
4The hybridisation was carried over by a company called Expression Analysis, Inc. (Durham, NC, US).
Www pages for more information about products and services: http://www.expressionanalysis.com/.
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such as false positives in homozygous regions and differences in SNP densities, are further
discussed in Section 7. The sample donors were not close relatives of each other. Most
reference samples (41) are from The Finnish Red Cross (FRC) and the rest 10 samples
were from the previous studies of Department of Medical Genetics. The samples from
FRC were part of their leukaemia studies and they have been takes from healthy siblings
of leukaemia patients.
The genotyping was performed for all chromosomes but only autosome data has been used
in our study. Sex chromosomes have been left out from the studies because male samples
have a single copy of both chromosomes X and Y and females have a diploid composition
of chromosomes X. Mutations in chromosome X would affect in phenotypes of males
even if they are of recessive type and such hemizygous effects can be seen right from
the pedigrees without advanced analysis. Chromosome Y could be analysed from male
samples only, which would reduce the amount of available data. The chromosome has
been excluded because of the small number of samples and their constant hemizygosity.
AffyExportParser (described in Section 6.2.1) was used to convert sample data into form
of genotype matrices (Figure 10) used by statistical software. SNPs without a known
physical locus (466 SNPs from XbaI chip and 385 SNPs from HindIII chip) and those
found in sex chromosomes were dropped during the conversion. The total amount of
SNPs left for the study was 57290 (XbaI) + 55700 (HindIII) = 112990 for the patients
and 57290 for each reference sample.
6.2 Programs
The conversion from SNP-microarray measurements to biological knowledge involves a
series of computational procedures implemented in various programs. In this section we
describe the software we have been using in this study. The exact versions of databases
and software distributions are listed in Table 4.
A schematic view of the data flow is given in Figure 8. The initial SNP data comes in a
platform specific format and we start by converting it into a generic form of chromosome
size matrices of two allele genotypes. The conversion was done in several steps using
Affymetrix software for the extraction of genotypes and our own code (analysis steps) to
merge all chips and individuals into matrices.
The data analysis starts by importing the hybridisation measurements of each sample into
a local database. Affymetrix Data Transfer Tool (DTT) reads Affymetrix .CEL, .CPH,
and .EXP files created during the array scanning and restores them into a pool of all
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Program version
Affymetrix Data Transfer Tool 1.1.0
Affymetrix GTYPE 4.0
CohortComparator 1.3
Ensembl genome database 40.36b
fastPHASE 1.1.4
JAVATM2 Platform Standard Edition 1.5.0
R 2.4.0
Table 4: Version numbers of databases and software used in this study
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Figure 8: Steps of the data analysis.
experiments. The local database can be used along with Affymetrix software but the
vendor specific storage is difficult to access for external applications. Genotypes can
be extracted from the database by using Affymetrix GTYPE genotyping program, which
takes care of probe annotations, background corrections and normalizations of the data.
Probe annotations are loaded automatically from the Affymetrix web site and they are
used to identify feature sequences, to features into SNP alleles and associated locations
in human genome. The background correction is done by comparing the signals of the
perfect match probes to those of mismatch probes.
Figure 9 illustrates the format of the Affymetrix GTYPE export being a tab delimited
text file consisting of rows of SNPs and their attributes. The first two lines are headers
describing the file title and attribute names.
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Dynamic Model Mapping Analysis
SNP ID Chromosome Physical Position dbSNP RS ID TSC ID EA05021. . .Call EA05021. . .Confidence
1 SNP_A-1746877 0 BB 0.000488
2 SNP_A-1709473 0 TSC64405 AA 0.002930
3 SNP_A-1686560 0 TSC648024 AB 0.000488
4 SNP_A-1731395 0 TSC1587919 BB 0.126953
5 SNP_A-1685046 0 TSC393273 AB 0.005859
6 SNP_A-1707717 0 TSC618160 AB 0.000488
7 SNP_A-1692726 0 TSC1216283 AA 0.000488
.
.
.
1169 SNP_A-1658184 1 58519238 rs3861824 TSC1332643 NoCall 0.669922
1169 SNP_A-1658184 1 58519238 rs3861824 TSC1332643 NoCall 0.669922
1170 SNP_A-1754126 1 58561256 rs7367176 BB 0.000488
1171 SNP_A-1663466 1 58570387 rs10489813 BB 0.000488
Figure 9: Affymetrix GTYPE export file example.
6.2.1 AffyExportParser
AffyExportParser is a Java program that takes its input in the form of Affymetrix GTYPE
export files (Figure 9) and produces a set of tab separated text files that can be used
in R [R D06] and other statistical software. AffyExportParser is especially suitable for
platforms with two chips because it is capable of merging SNP measurements of both
chips into a single vector but it can be used as a standard tool for the input file construction
even on one chip platforms.
AffyExportParser expects that the content of the input files is sorted by chromosome
number and physical location of SNP. The sorting can be done in Affymetrix GTYPE
before the data export and thus it has not been integrated into AffyExportParser. SNPs
are all in the same order in unsorted export files and thus it is possible to sort them in
O(n×k) time using a constant list of indices of input rows in the output order. The memory
requirement of such algorithm would be O(k) if we first read the whole sample data into
main memory and then print them in the order of the index list. The time efficiency can
be compromised for the sake of better memory efficiency depending on the amount of
free memory and the size of k but that should not become an issue with contemporary
computers and microarrays of size k / 106.
The time and memory efficiency has been a priority during the implementation of Affy-
ExportParser. Each chip data input file gets scanned just once and there are no more than
two such files (in case of file merging between two chips) open at a time. The files are
read line by line (=SNP by SNP) and merge algorithm is applied so that only one line
is kept in memory for each file. The memory consumption of the algorithm is obviously
O(k), while the time consumption is O(n × k).
Each Affymetrix GTYPE export file contains all SNPs of the chip concerned but the anal-
ysis is usually conducted in a chromosome specific manner. AffyExportParser works
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so that it keeps track of the chromosome that it is processing and the output file for the
genotypes is changed according to it. New files are created during the iteration of the
first sample and the next samples are appending into these files. A partial example of
such output file can be seen in Figure 10. The first column contains the sample name and
the following tab separated columns represent the corresponding haplotype combinations
(A=aa, X=ab, B=bb, N=missing value). All SNPs are in order based on their physical
locations, which are stored into separate files. The locus files are simple chromosome
specific lists of base pair rows in the same order as the matrix columns. Locus lists are
created during the iteration of the first sample but they are used by all other iterations to
double check that the order of SNPs is identical.
C1001 A B B A A A B B B A X A A A A A B B X X X B B B B N B B . . .
C100 A B B A A A B A B X X A A A X A B B A A B B A B B B B B . . .
C135 A B B A A A B X B A A A A A B A B B X A X B B B B B B B . . .
C182 A B B A A A B X B A A A A A A X B A X X X X B B B X X B . . .
C205 A B B A A A B X B A A A A A X A B X X X X X B B B X B B . . .
C206 X B B A A A B X B X X X X A X A B X A X B X B B X N N B . . .
C216 A B B A A A B B B A A A A A B A B B X A X B X N X A B B . . .
...
Figure 10: An example of AffyExportParser output matrix.
The fact that we had only half as dense SNP set for the reference samples was causing
problems in detecting the homozygous regions and fine tuning the parameters as described
in Section 7. One way of reducing the number of false positives is to use haplotype data
for the estimation of the missing SNPs. The linkage between neighbour SNPs is quite
high and the values of the missing SNPs are likely to match the SNPs of those haplotypes
of the population that are compatible with the SNPs around the missing values. The
process of estimating the haplotypes differs depending on whether the samples are taken
from relatives with a known pedigree or only distantly related individuals of the same
population.
6.2.2 fastPHASE
A program called fastPHASE written in University of Washington can be used to estimate
haplotypes from SNP data sets [SS06]. The major advantage of fastPHASE is in its
scalability. The authors of fastPHASE have also published another haplotyping program
called PHASE [SD03] but the amount of data we had (for example in chromosome 2 there
were 10339 SNPs in 93 samples) was too much for it. The processing of all chromosomes
took only some hours using fastPHASE.
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Two data conversion programs were written in order to use fastPHASE: one that converts
AffyExportParser output matrices to fastPHASE input files and another one for the re-
verse conversion of the haplotype outputs. The programs can be used for the construction
of an additional set of data files (after the step “Merge sample files” in Figure 8) if the
resolution of the reference and data sets differs. The original AffyExportParser outputs
should be kept for the analysis of the deletions and effects of the missing value estimation.
6.2.3 CohortComparator
CohortComparator is a program that can be used for the actual comparison between the
patient and reference samples. CohortComparator detects the homozygous regions (see
Section 4.1) from each sample, separates alleles of the regions, compares RD to RR and
calculates scores for the differences. CohortComparator produces a PostScript image
(see Appendix 1) of each chromosome and a list of interesting chromosomal regions.
CohortComparator is technically a set of R scripts that are combined into an application.
A special code library called AsserTools encapsulates almost all generic procedures that
are used within the main program. The separately organized code library has been written
in a recyclable manner so that it can be used together with other R programs. AsserTools
provides its own framework for the unit testing. Unit tests are used to verify the proce-
dures provided by the code library itself but the framework is readily useable for other R
scripts as well.
A pseudocode of CohortComparator is given in Figure 11. The pseudocode does not
explain the details nor naming conventions of the original source code but it follows the
logical structure of the algorithm. The functions of the pseudocode are explained in the
next paragraphs.
ReadConfigurations() reads the execution parameters such as the folder and file name
options for the input and output files. The parameters of analysis, the method of score
calculation, and the definition of the homozygous region are also read during the start.
A complete list of the runtime configuration of CohortComparator can be found from
Appendix 2.
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ReadConfigurations()1
results ← ∅2
members ← ∅3
for (chr in chromosome.set) {4
loc ← LoadPhysicalSNPLocations(chr)5
SD ← LoadPatientData(chr)6
SR ← LoadReferenceData(chr)7
RD ← HomozygousRegions(SD, loc)8
RR ← HomozygousRegions(SR, loc)9
homozygousRegions ← free(RR) \ free(RD)10
t ← TestNormality(RD)11
col ← SetAlleleColors(RR)12
RDa ← AlleleRegions(SD, RD, col)13
RRa ← AlleleRegions(SR, RR, col)14
alleleRegions ← free(RRa) \ free(RDa)15
chrResults ← homozygousRegions ∪ alleleRegions16
chrMembers ← RegionMembers(chrResults, RDa)17
CD ← CompoundRegions(chrResults, chrMembers, SD, SD)18
CR ← CompoundRegions(chrResults, chrMembers, SD, SR)19
results ← results ∪ chrResults20
members ← members ∪ chrMembers21
: Create chromosome specific outputs22
: graph (see Appendix 1) and23
: a text file for region loci.24
PrintChromosome(chr, t, col, loc, RRa, RDa, CR, CD)25
}26
results ←MergeRegions(results)27
results ←SortByScores(results)28
PrintInterstingRegions(results)29
Figure 11: Logical structure of CohortComparator.
LoadPhysicalSNPLocations() is a simple text parsing routine that converts the chro-
mosome specific SNP locus lists of the reference and the patient data into lists (loc) that
can be used together with S and R matrices. The locus list files are created by AffyExport-
Parser and the order of loci follows the order of columns in sample matrices. The sample
matrices are loaded using LoadPatientData() and LoadReferenceData().
HomozygousRegions() is essentially a loop that calls findHomozygousRegions()
function (template code is shown in Figure 5) for each sample (row) of the given ma-
trix. The locus information is required only if the lengths (l,w) are given in base pairs.
The recognition of homozygous regions and deletions are both done during the same al-
lele scan in CohortComparator but the code related to deletions is omitted for simplicity.
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The chromosome regions containing less than given amount of overlapping regions (see
f .limit.d and f .limit.r in Appendix 2) are calculated using free() and the interesting re-
gions are found by calculating the set minus of reference and patient free regions. The
interesting regions of homozygosity are stored into homozygousRegions list.
The distribution of the total length of homozygous regions in patient samples is tested
against the null hypothesis that it follows the normal distribution. TestNormality()
function performs a Shapiro-Wilk normality test [SW65] and returns the p-value that is
shown on the result graph.
The analysis of alleles is based on a reference vector (variable col in Figure 11) that
divides alleles a and b into two haplotypes based on their frequencies:
colc =

a, if frequency(aa,Sc) ≥ frequency(bb,Sc)
b, else.
(9)
The vector of the most common alleles is produced in function SetAlleleColors() and
it is used by AlleleRegions() to tell whether a SNP represents the common haplotype.
AlleleRegions() compares col vector against each corresponding SNP of the given
homozygous regions. The resulting set of regions contains the same homozygous regions
that were given to the function but they have been split into haplotypes red and blue.
The red haplotype represents the regions where the sample genotype Sc is homozygous to
allele colc and the blue refers to the regions of complement homozygosity. Heterozygous
SNPs (the gaps), improperly hybridised SNPs, and SNPs that are not listed in col vector
are ignored. The base pair division between the haplotype boundaries favours the blue
regions so that the rare allele gets expanded to the limiting SNPs. The division policy
maximises the sensitivity of detecting allele differences because the blue haplotype is
unusual in references.
CompoundRegions() lists those regions that could be possible compound heterozygotes
of the homozygous regions. The concept of the possible compound heterozygote and the
detection algorithm are described in Section 4.4.
6.2.4 RegionAnnotator
RegionAnnotator is a Java program that can be used to collect biological information
about the interesting regions found by CohortComparator. RegionAnnotator is capable
of reading the result lists of CohortComparator and it can be given a score limit that
tells which regions are worth a further analysis. Each interesting region is queried against
Ensembl database for its biological content. The query interface is based on publicly
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chromosome start end score type samples
14 75683432 76374502 888394 1 C705,C93
14 93952397 94431793 875499 1 C383,C705
2 45292467 46457469 640784 1 C828,C835,C88
2 34804935 34858768 631390 1 C135,C828,C897
2 36444241 36566423 602266 1 C697,C828
6 24461416 24898997 455349 3 C69,C705,C828
1 43494738 44556103 454017 1 C279,C697,C702
5 102881726 103082033 443566 3 C279,C402,C770,C828,C897
13 53813508 54217913 401100 1 C222,C322,C383,C439,C791
13 62534529 62719498 364604 1 C322,C622
12 111494162 112203186 335760 1 C205,C222,C619
16 22705354 24061164 329410 1 C383,C442
...
Figure 12: An example of the list of interesting regions. The file consists of rows of interesting
regions sorted in descending order by the score. Each line starts with the location information
given in base pairs followed by the actual score. The type of the region (1=region of homozygosity,
2=interesting allele, and 3=a joint region of the previous types) is given before a list of samples
sharing the interesting feature.
available Ensembl API (Ensj) Java library that provides an object oriented view to the
genomes and takes care of all object-relational mappings. Ensj is provided by the En-
sembl hosts The Wellcome Trust Sanger Institute and European Bioinformatics Institute
and it can be downloaded from the Ensembl web site5.
The input format of RegionAnnotator is compatible with list of interesting regions pro-
duced by CohortComparator (an example is given in Figure 12) but only first three
columns (chromosome number, start locus, and end locus) are mandatory. The scores
can be used to limit annotation to the best scored regions if a score limit is given to
RegionAnnotator. The input format of the program has been kept simple so that its use
is not limited to CohortComparator but it can be used for general interests of querying
transcripts encoded by the given parts of the genome.
5Ensembl genome browser can be found from http://www.ensembl.org/.
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7 Results
The amount of SNP data used in this colorectal cancer study was so huge that all methods
of analysis needed to be scalable. The final analysis was completed with 51 reference and
42 patient samples each consisting of 57290 and 112990 SNPs, respectively. The amount
of data to be processed simultaneously was reduced by splitting haplotype matrices of
both data sets into chromosome specific files.
The important questions to be answered were:
1. Which are the loci of homozygous regions shared by some patients but absent in
references?
2. Which are the loci of homozygous regions with alleles absent in references?
3. Are there any homozygous deletions shared by some patients but absent in refer-
ences?
4. Which are the samples sharing any of these features?
5. What are the genes in these regions?
CohortComparator and RegionAnnotator were written in order to answer these ques-
tions. The designing, construction, testing, optimisation and analysis of the applications
are my most important contributions to this study. CohortComparator takes many pa-
rameters (see Appendix 2) that can be fine tuned based on what kind of experiments it is
used for. Changing these parameters would be hard and it could lead to misleading results
unless the meaning of the argument is well understood. The analyses of these arguments
are given in sections 7.2 and 7.3.
7.1 Distribution of homozygous SNPs
The first step in comparing the data sets SD and SR was to check whether they have similar
distributions of homozygosity in all SNPs. The high level comparison was done because
it was not known how similar the distributions would be. The interesting regions could
be detected without a complex analysis if the distributions would differ enough in certain
regions.
Homozygosities were calculated for each SNP in both data sets and visualised in a graph.
Rates of homozygous samples were compared between both data sets and for each SNP
in order to see whether the differences were of any significance. Uncorrected p-values
were smoothed with the same locally weighted linear regression (LOWESS function)
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[Cle79] as the homozygosity levels. Only those p-values are drawn to the graph, which
are less than 0.2. A pair of examples of homozygosity level comparison graphs can be
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Figure 13: Two example graphs of homozygosity levels. The vertical axis represents the
smoothed ratio of homozygous genotypes within the sample set. The chromosomal loci are shown
on x-axis. The vertical green bars show the positive differences between the patient and reference
sets i.e. the regions that have more homozygosity in patient data.
seen in Figure 13. Chromosome 5 is shown in here so that it can be compared against
other figures given in this thesis (like those in Appendix 1). The graph of chromosome
17 has been chosen here as it has clear regions of smoothed p-values less than 0.2. The
smoothing of the p-values is a visualisation trick to keep values comparable in the graph
and to emphasize those regions that may harbour interesting differences. The statistical
relevance of such measures is, however, not clear. The application of a real false discovery
rate correction [PC06] revealed no significant findings in any chromosome. The result
was expected because the sample size was relative small comparing to number of SNPs
(n≪k) and because of the big variance in p-values. The statistical comparison of allele
distributions of each SNP was not sensitive enough to detect weak signals of continuous
homozygous regions as there were other homozygous SNPs (fractions with length < l)
confusing the test.
7.2 Determination of a significant region length
The chance of getting homozygous region by chance was analysed using randomly gen-
erated samples in linkage equilibrium. The frequencies of aa, ab, and bb were calculated
from each cancer patient sample and 51 random samples of chromosome 5 were gener-
ated. The SNP specific genotype frequencies were used to weight the genotype proba-
bilities and each SNP was assigned a value independently. Both, number of homozygous
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regions and their chromosome coverage, were calculated with different values of l and
the same analysis was completed with the original cancer patient data. The results are
given in Figure 14. The number of homozygous regions found from the random samples
decreased well below 0.05, when l = 54 but an average of ∼ 4.67 homozygous regions
were still found from the patient samples. The SNP genotypes of the real samples were
clearly dependent on surrounding SNPs and distinctive from the independent genotypes
of random data.
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Figure 14: The distribution of homozygous regions of cancer patients in comparison to
random data. The y-axes of both figures are in logarithmic scale and the values are nor-
malised in according to the number of samples analysed.
An increase in minimum length of the homozygous region (l) of interest decreases the
number of regions we expect to see but the chance of getting such regions without a bio-
logical relationship decreases. Biological relevance of the findings is important but on the
other hand we should lose as little information as possible. The balance between these
two exclusive objectives is challenging to answer analytically because the biological rel-
evance cannot be determined a priori. Long regions are more likely to be autozygous
[Woo04] but the mutations we are interested in may be on shorter fragments. Only some
estimates of the evolutional background of the haplotypes can be done (see Section 4.4)
since we do not know the pre-existed genomes nor complete pedigrees. Figure 16 illus-
trates the synergism of l parameter, when adjusted simultaneously in both patient data
and reference data (parameters l.limit.d and l.limit.r in the figure). Figure 15 illustrates
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Figure 15: Total amount of interesting regions in comparison to lD (on the left) and lR (on the
right). In both graphs, the length limit of the other cohort is kept constant (lR = 25, lD = 55). The
value of the length limit is given on the y-axis (in numbers of SNPs). The red curve represents the
total length of the interesting regions (blue bars) and it follows the scale of the x-axis. The same
axis has been used for the physical locations of the regions but in that case the base pairs should
be considered as chromosome loci.
the separated examination of both parameters 6. The horizontal bars represent interest-
ing regions found in chromosome 5. The length of the bar does not reflect the length of
individual homozygous regions of the samples but it consists of at least two overlaps of
such features (homozygosity or allele) that are not present in references. The definition
of interesting region is further discussed in Section 4.3. Numbers of interesting regions
decreases if reference set criteria are relaxed or they are tightened in data set. The balance
between the two exclusive length limits is met around the values of lD = 54, lR = 27.
The clear imbalance in accuracy between the patient (HindIII and XbaI chips used) and
reference (no HindIII chip data) sets lead to difficulties in parameter determination in
order to keep both sets comparable. Region length limit (lR) for the reference set was esti-
mated so that the physical length of the regions found became the same in both data sets:
min(length(RD)) = min(length(RR)). The effect of data set differences was eliminated by
using XbaI SNPs of the cancer patient samples as references. lD was set to 55 and the
analysis was conducted using different values of lR. The lengths of the shortest regions of
both cohorts were compared by eye and they were found to be almost equal when lR = 25.
Results of this experiment can be seen in Figure 24 in Appendix 1.
6Figures 16 and 15 were generated using gap distance method with parameters: d = 8, f .limit.d = 0.03,
and f .limit.r = 0. Constants used in Figure 15 were l.limit.d = 55 and l.limit.r = 25.
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Effect of parameters: l.limit.d, l.limit.r
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Figure 16: The compound effect of l parameter. Y-axis consists of pairs of length limits (lD, lR).
The red curve depicts the total length of interesting regions.
7.3 Properties of the region detection algorithms
The window length parameter w used in sliding window method is not critical for the re-
sults. Combinations of different window lengths for reference and patient data show only
minor differences when 1/g ≤ w ≤ l. The lower bound of w ≥ 1/g allows at least one
heterozygous SNP within the window whereas the gap acceptance benefits of the method
are lost with the shorter windows (each heterozygous SNP interrupts the homozygous
region). Window sizes greater than l are somewhat irrelevant since we are interested in
shorter homozygous regions surrounded by heterozygous continuums. A too long window
would not allow gap in such islands because the g would be exhausted by the surround-
ings. An example set of experiments on chromosome 5 is given in Figure 17. There are
two components in gap ratio as defined in “window” method of CohortComparator. The
first component tells the window length (w) and the second one gives the maximum ratio
of heterozygous SNPs (g) within the window. The second component is kept constant
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(0.1) in these experiments and omitted from the figure. The minimum length of the re-
gions of interest (l) is 25 for the reference set and 55 for the patient samples 7. There are
locus (Mbp)
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Figure 17: Effects of the length of the sliding window in respect to the interesting regions found.
The window lengths for the patient samples and the references are given on y-axis as tuples of
(wD, wR). The window lengths are measured as a number of SNPs. Total length of the interesting
regions is shown with a red curve.
not many differences between those rows in Figure 17 that fit into range (10–55, 10–25)
and even the rows outside of the range are fairly similar. The considerably big leap from
row (20, 5) to row (20, 10) can be explained by the fact that no heterozygous gaps are
allowed when the window length is less than 10 whereas at least one heterozygous SNP
fits into the range when w ≥ 10. Saturated patterns outside of the range are produced
by the gapless homozygous regions. The pure regions are rare comparing to those with
gaps and we observe more regions when the parameter saturates in reference data (less
filtering) and only few short regions in case of patient data (less region candidates).
The use of gap distance method means the substitution of parameters w and g by the gap
7Other parameters used in Figure 17 were: f .limit.d = 0.03, and f .limit.r = 0.
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Effect of parameters: gapRate.d, gapRate.r
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Figure 18: Minimum distance between heterozygous SNPs (dD, dR). The blue bars represent
interesting regions found from the chromosome 5 using the gap distance method with differ-
ent values of dD, dR as shown on the left. The other parameters used in this example are:
s = 1, f .limit.d = 0.03, f .limit.r = 0. The total length of the interesting regions is illustrated
by the red curve.
distance measure d. The average distance between the gaps can be given as 1/g−1 but the
method gives no compensation to gaps with distances below the d although they would
have been surrounded by long and gapless sequences. The ignorance of overall gap rate
means that d ≤ 1/g − 1. The difference between thed and g measures depends on the
distribution of the gaps, where the equality holds for the uniform distribution only.
It is not surprising that the changes in d seem to follow the same pattern as changes
in g as there is a close relationship between these two parameters. The effects of the
parameter to the list of interesting regions are illustrated in Figure 18. The total length of
the interesting regions increases as the distance between the gaps becomes longer. Reason
for this phenomenon can be found from the amount of homozygous regions within the
reference set. Features of the patient data are less likely to be ignored as the amount of
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reference regions gets smaller. The saturation of the regions occurs when the dD becomes
greater than 25 and dR becomes greater than dD/2. The regions found after the saturation
are almost solely determined by the parameters l and s.
An optional support for base pair metrics in SNP distances has been implemented into
CohortComparator as an alternative to counts of intermediate SNPs. The base pair dis-
tances can be used in order to compensate the effects of the non-uniform SNP distribution.
The length of the sliding window and l were both calculated in base pairs when bpLength
option was turned on. The advantage of this approach is that the parameters are automat-
ically calibrated to both data sets with different SNP densities (see Section 6.1) but the
probability of getting false positives in areas with low SNP densities was increased as
the amount of SNPs associated to each region varied. Figure 23 illustrates how the low
density areas close to telomeres (both ends) and the centromere (46–50Mbp) contain ho-
mozygous regions not present in Figure 21, which was created using SNP limits lR = 25
and lD = 55. The DNA sequences of telomeres and centromeres are typically quite con-
served, which advocates real regions but the true existence of mutations remains obscure
unless the samples are sequenced.
Gap distance, gap ratio, and sliding window methods are all equal (to R in Equation 2)
if no gaps are allowed. The behaviour of these methods has been empirically compared
using realistic values of parameters l, s, d, g, and w as suggested by the analysis explained
in this section. An example set of results of all three methods is given in Figure 19. It can
be seen that the interesting regions are found from the same areas but the exact loci varies
between the algorithms. All algorithms agree on 34 regions but the variation around these
regions is enough to change the list of affected genes. The analysis of the scores of the
interesting regions was performed with the same method as in Figure 7. The method is
not as accurate with one chromosome as it is with a genome wide data but the limit of
11800 was chosen based on the suggested values of 14313 (gap distance), 12827 (sliding
window), and 11826 (gap ratio). Comparison of the regions exceeding the limit revealed
that all 5 regions found by the gap distance method were also found by the other two
methods. The results of gap ratio method included 6 regions that were not in top 5 given
by the gap distance method. Only one of the six regions returned by the gap ratio method
was also detected by the sliding window. Sliding window had 3 interesting regions with
scores greater than 11800 not shown in the list of gap distance method. Top best scoring
regions were considered to be the same if they overlapped but differences in the limit of
the regions were observed in regular basis. The comparison of the sample lists associated
to each region revealed cases were a sample was associated to the region by one algorithm
but left out by another one.
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Figure 19: Homozygous regions as found by A) the gap distance, B) the sliding window, and
C) the gap ratio methods. This example study of the chromosome 5 illustrates the small variation
between the definitions of the homozygous regions. A detailed explanation of the formalism used
in these graphs is given in Appendix 1.
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7.4 Mutation detection probability
A criterion to measure the usefulness of a candidate region detection method is its ability
to detect mutation sites and to reduce the length of genome under surveillance. In this
section we describe how likely our method labels a mutation site as a candidate region.
The probability of considering a region to be interesting (Pint) is a joint probability of
having at least tD overlapping homozygous regions (PD) in case cohort and a probability
of no more than tR overlapping regions in references (1 − PR):
Pint = PD × (1 − PR). (10)
Let hD be the probability of observing a homozygous region at given locus. The prob-
ability hD is defined for the sample space of patients and it should8 represent relative
frequency of homozygous regions at the locus. The probability of at least tD overlapping
regions can be calculated using the probability mass function of binomial distribution:
PD(hD, nD, tD) = 1 −
tD−1∑
i=0
(
nD
i
)
(hD)i(1 − hD)nD−i tD ∈ [1, nD]. (11)
A similar approach can be applied to references. First, hR is defined as the probability of
having a homozygous region in one sample at a certain locus. Secondly, the probability
of at least tR overlapping regions is determined:
PR(hR, nR, tR) =

1 −
∑tR−1
i=0
(
nR
i
)
(hR)i(1 − hR)nR−i, tR ∈ [1, nR],
1 − (1 − hR)nR , tR = 0. (12)
Equation 12 has been defined separately for tR = 0 to avoid negative indices in sum
function but otherwise it has been derived from the same binomial probability function as
Equation 11.
In comparison of homozygous regions we assume that PD > PR for those regions that
contain mutations significant to observed phenotype. The reasoning for this assumption is
in the definition of the case sample space that suggests a recessive phenotype. Controls are
less likely to share the same homozygous haplotype as they express a different phenotype.
Limits of tD and tR represent prior hypotheses of how many overlapping homozygous re-
gions are expected in the cohorts. The values of these limits could be estimated using their
expectation values if hD and hR are known: tD = nD×hD and tR = nR×hR. Determination
of realistic limits provides a reasonable balance between false positives and sensitivity.
8Assuming that the detections of homozygous regions causes no false positives or false negatives.
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Obviously, Pint can be maximised by using values tD = 1 and tR = nR but that would make
no use of reference samples and all regions with at least one homozygous sample would
be classified interesting. The strengthening of the limits decreases the number of possi-
bly interesting loci. On the other hand, it becomes more likely that the mutation region
contains too few overlapping homozygous regions in case samples or there would be too
many mutant haplotypes in reference set.
In this simulation, values of Pint have been estimated using Equation 10. Simulations have
been conducted using various cohort sizes (assuming nD = nR), where hD has been fixed
to 0.05 and hR has varied between 0 and 0.05. Examples of these simulations are shown in
Figure 20. Each graph represents Pint estimates (red lines) for one n with two alternative
hD (0.05 and 0.1). The fluctuation of the lines is caused by the discrete expectation value
estimates of tR; the sensitivity of the method increases as more reference regions are toler-
ated. Statistical difference between the cohorts is measured using Kolmogorov-Smirnov
test (blue lines) [Pre02] with a null hypothesis that tD = tR. The shown probability values
for the null hypothesis have been calculated as a mean of tests applied to 100 random
cohort pairs. The cohorts were generated using values of hD and hR.
It can be seen in Figure 20 that the comparison of homozygous regions is suitable for small
cohorts (n < 100) but does not benefit from the additional information provided by larger
cohorts. The statistical analysis of distributions may be more practical if there are a vast
number of samples available. The differences between the distributions of homozygous
regions between the cohorts are so minor that the statistical significance remains low even
if n = 1000. Pint decreases rapidly in function of hR if the change is not compensated
by the increase in tR. The observation is quite obvious as the increase in tR increases the
change of having mutation haplotypes in reference samples. The changes in hD are well
tolerated as limnD→∞ PD = 1, when hD < 1. This means that a region is considered to
be interesting if the amount of overlapping regions exceeds limit tD and no difference is
made on how far this limit was exceeded.
7.5 Effects of the haplotyping
The amount of homozygous regions found in the reference set is higher than in experiment
data with HindIII SNPs included because less homozygous SNPs are needed and such
regions may be caused my non-autozygous regions of (almost) monoalleleic markers. The
dramatic effect of false positives caused by the sparse SNP set can be seen by comparing
Figure 24 and Figure 25. Both figures have been created using the patient data but the
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Figure 20: Simulated values of mutation detection probabilities. Red lines represent a probability
of labelling a mutation to an interesting region. The chance of a homozygous region at the mutation
site has been set to 1/20 (solid lines) and 1/10 (dashed lines). The same probability for the
reference set is shown on the x-axis. Kolmogorov-Smirnov test probabilities are shown in blue.
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SNP resolution differs between the data sets. The first figure illustrates the case where the
reference set lacks the HindIII information. The lower SNP resolution leads to a greater
amount of homozygous regions. No interesting regions are expected in these figures as
the samples are compared to themselves. However, the second figure contains interesting
regions all over the chromosome because the dense set of homozygous regions found from
the sparse SNP set is not compensated by the homozygous regions found from the HindIII
and XbaI data. The resolution of 105 SNPs may sound extremely good but it seems that
our method suffers from having fewer markers for a genome wide analysis. Further, it has
been reported that a genome wide haplotype analysis may require as many as 106 SNPs
[HP04]. The vast amount of questionable homozygous regions found from the reference
data was likely to mask some real mutations.
The haplotype estimation of missing HindIII values was tried in order to increase lR and to
reduce the false positives that would not meet the selection criteria if measured with XbaI
chip. The estimation was conducted by using fastPHASE haplotype prediction software.
The haplotypes of the population were calculated from all samples (SD and SR) and the
HindIII SNPs of the references were set to missing values. All information about the
HindIII alleles comes from the patient data, which may lead to a bias towards patient
haplotypes. The mutation in interest is probably shared by only few individuals (see
Section 6) where the rest of the samples are “normal”. The alleles of the normal samples
are more likely to bind the references as they share the common haplotype whereas the
mutation is likely to differ in its XbaI constitution also. The computationally predicted
values were converted back to SNP data matrices with the full SNP resolution and the
analysis was conducted using the original patient data parameters for both data sets.
The results of the haplotype estimations were in better balance than the original results,
what comes to the spatial densities of homozygous regions along the chromosomes. An
example of the results in chromosome 5 is given in Figure 22 and the same chromosome is
shown without haplotype estimations in Figure 21. The chromosomal areas of interesting
regions are quite well conserved between the original data and the haplotype estimates but
the short fragments of the original data have fused into wider regions. The genome wide
analysis of the original data returned 767 interesting regions covering total of 70.868960
Mbp. The estimation of the haplotypes decreased the number homozygous regions in
reference data, which led to 1940 interesting regions with total of length of 199.752217
Mbp. The average length of an interesting region is increased9 by 10557.5 bp, which is
over 28 times more than the change in score limit that is calculated as described in Figure
9from 92397.6 to 102965.1 bp
52
count minimum median mean maximum 1012σ2
references
before 7794 97770 1079000 1395000 47270000 2.230
after 3831 280200 1211000 1530000 29030000 1.788
NoCalls 3680 280200 1206000 1518000 29030000 1.660
patients
before 2428 262800 1232000 1676000 34580000 3.108
after 2638 262800 1244000 1685000 34580000 3.239
all samples
before 10222 97770 1121000 1462000 47270000 2.452
after 6469 262800 1226000 1593000 34580000 2.385
NoCalls 6118 262800 1216000 1581000 34580000 2.240
Table 5: Length distribution of the homozygous regions before and after the haplotype estima-
tion of the missing data. NoCalls rows represent cases, where the haplotype estimated data was
populated with NoCall values copied from the original XbaI data. Genome wide counts of the
homozygous regions are given on the first column. The region lengths are given in base pairs and
the variance (σ2) is shown on the last column.
7. The original score limit of 12987 was replaced with 13357 due the estimation of the
haplotypes. The amount of regions exceeding the limit was increased from 63 to 165
regions.
The lengths of the homozygous regions and their total number were counter before and
after the haplotype estimation. The preceding values are summarised in Table 5. The
effects of the haplotype estimations into region lengths are first listed separately for both
data sets and next together to illustrate their synergy. More than half of the reference
values of the last data set consist of estimated values origin from the patient data. An
extensive decrease in homozygous regions would be seen if the estimation was a random
process as the probability of getting a sequence of 55 homozygous SNPs is seemingly low.
The median length of the regions was increasing close to that of cancer patients, although
the number of homozygous regions was almost halved. Taking this into consideration
there is a reason to believe that the number of regions was not reduced that much because
of a poor estimation algorithm but because of the changes in length limit.
7.6 Biological content of the candidate regions
Annotations of the all 1940 interesting regions revealed 2041 genes classified as novel or
known. The results of the comparison between the genes and the colorectal cancer genes
given in SNPs3D are listed in Table 6. The association between the SNPs3D gene name
and the region annotation is based on a simple text search. The order of the genes reflects
53
the association strength between the gene and the colon cancer as given by SNPs3D.
The original gene annotation set was also compared against the CRC genes listed in
[Sjö06] and only five genes were observed to overlap between these two lists and GFRA1
was associated to RET based on its description. The list of genes revealed by the text
search is given in Table 7. GFRA1 was the only gene found from both tables 6 and 7.
SNDs3D ref. locus gene name description
MLH3 14: 74553239-74587886 MLH3 DNA mismatch repair protein Mlh3 (MutL protein homolog 3).
ATM 11: 107598769-107745036 ATM Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T, mutated).
FHIT 3: 59712992-60497735 FHIT Bis(5’-adenosyl)-triphosphatase (EC 3.6.1.29) (Diadenosine 5’,5”’- P1,P3-triphosphate hydrolase) (Dinucleosidet-
riphosphatase) (AP3A hydrolase) (AP3AASE) (Fragile histidine triad protein).
ERBB2 17: 35104766-35138441 ERBB2 Receptor tyrosine-protein kinase erbB-2 precursor (EC 2.7.10.1) (p185erbB2) (C-erbB-2) (NEU proto-oncogene) (Ty-
rosine kinase-type cell surface receptor HER2) (MLN 19).
DPYD 1: 97315887-98159193 DPYD Dihydropyrimidine dehydrogenase [NADP+] precursor (EC 1.3.1.2) (DPD) (DHPDHase) (Dihydrouracil dehydroge-
nase) (Dihydrothymine dehydrogenase).
NFKB1 4: 103641518-103757506 NFKB1 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP- 1) [Contains: Nuclear factor NF-kappa-B
p50 subunit].
MAP2K4 17: 11864866-11987865 MAP2K4 Dual specificity mitogen-activated protein kinase kinase 4 (EC 2.7.12.2) (MAP kinase kinase 4) (JNK-activating kinase
1) (c-Jun N-terminal kinase kinase 1) (JNKK) (SAPK/ERK kinase 1) (SEK1).
TNF 6: 24758184-24775240 TTRAP TRAF and TNF receptor-associated protein (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII).
SELP 1: 167824661-167866023 SELP P-selectin precursor (Granule membrane protein 140) (GMP-140) (PADGEM) (Leukocyte-endothelial cell adhesion
molecule 3) (LECAM3) (CD62P antigen).
CGA 6: 87851935-87861569 CGA Glycoprotein hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common subunit alpha) (Fol-
litropin alpha chain) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Lutropin alpha chain) (Luteinizing hor-
mone alpha chain)
GATA4 8: 11599122-11654920 GATA4 Transcription factor GATA-4 (GATA-binding factor 4).
PEX7 6: 137185410-137276752 PEX7 Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7).
PLA2G4A 1: 185064708-185224736 PLA2G4A Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phos-
phatidylcholine 2- acylhydrolase); Lysophospholipase (EC 3.1.1.5)].
DLC1 8: 12985243-13416766 DLC1 Rho-GTPase-activating protein 7 (Rho-type GTPase-activating protein 7) (Deleted in liver cancer 1 protein) (Dlc-1)
(HP protein) (StAR-related lipid transfer protein 12) (StARD12) (START domain-containing protein 12).
WNT5A 3: 55479112-55489996 WNT5A Protein Wnt-5a precursor.
FAP 2: 162735446-162808291 FAP Seprase (EC 3.4.21.-) (Fibroblast activation protein alpha) (Integral membrane serine protease) (170 kDa melanoma
membrane-bound gelatinase).
HMGB1 13: 29930884-30089729 HMGB1 High mobility group protein B1 (High mobility group protein 1) (HMG- 1).
SRC 3: 36397101-36564500 STAC SH3 and cysteine-rich domain-containing protein (SRC homology 3 and cysteine-rich domain protein).
SMARCA3 3: 150230604-150287007 SMARCA3 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3 (EC 3.6.1.-) (Su-
crose nonfermenting protein 2-like 3) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (Helicase-like
transcription factor)
RAD51 14: 67360014-68187315 RAD51L1 DNA repair protein RAD51 homolog 2 (R51H2) (RAD51-like protein 1) (Rad51B).
SELE 1: 167958406-167969827 SELE E-selectin precursor (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion
molecule 2) (LECAM2) (CD62E antigen).
MAPRE2 18: 30875379-30975820 MAPRE2 Microtubule-associated protein RP/EB family member 2 (APC-binding protein EB2) (End-binding protein 2) (EB2).
PHC1 12: 8959623-8985325 PHC1 Polyhomeotic-like protein 1 (hPH1) (Early development regulatory protein 1).
DVL3 3: 185355978-185374092 DVL3 Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3).
RING1 6: 33284255-33288477 RING1 Polycomb complex protein RING1 (RING finger protein 1).
MYB 6: 135544146-135582004 MYB Myb proto-oncogene protein (C-myb).
BDKRB1 14: 95799760-95800847 BDKRB1 B1 bradykinin receptor (BK-1 receptor) (B1R).
BDKRB2 14: 95740950-95780536 BDKRB2 B2 bradykinin receptor (BK-2 receptor) (B2R).
CCNG1 5: 162797155-162804598 CCNG1 Cyclin-G1 (Cyclin-G).
PLXDC1 17: 34473083-34561298 PLXDC1 Plexin domain-containing protein 1 precursor (Tumor endothelial marker 7) (Tumor endothelial marker 3).
ANTXR1 2: 69093993-69329804 ANTXR1 Anthrax toxin receptor 1 precursor (Tumor endothelial marker 8).
VCP 9: 35046061-35063246 VCP Transitional endoplasmic reticulum ATPase (TER ATPase) (15S Mg(2+)- ATPase p97 subunit) (Valosin-containing
protein) (VCP).
RPL31 2: 100985183-100989312 RPL31 60S ribosomal protein L31.
TGFA 2: 70527927-70634438 TGFA Transforming growth factor alpha precursor (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1).
CFTR 7: 116907253-117095951 CFTR Cystic fibrosis transmembrane conductance regulator (CFTR) (cAMP- dependent chloride channel) (ATP-binding cas-
sette transporter sub- family C member 7).
PPP1R1B 17: 35036705-35046403 PPP1R1B Dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32).
CYP2C9 10: 96688418-96739137 CYP2C9 Cytochrome P450 2C9 (EC 1.14.13.80) ((R)-limonene 6-monooxygenase) (EC 1.14.13.48) ((S)-limonene 6-
monooxygenase) (EC 1.14.13.49) ((S)- limonene 7-monooxygenase) (CYPIIC9) (P450 PB-1) (P450 MP-4/MP-8) (S-
mephenytoin 4-hydroxylase) (P-450MP).
ALOX5 10: 45189635-45261567 ALOX5 Arachidonate 5-lipoxygenase (EC 1.13.11.34) (5-lipoxygenase) (5-LO).
PLXDC2 10: 20145174-20609292 PLXDC2 Plexin domain-containing protein 2 precursor (Tumor endothelial marker 7-related protein).
TPBG 6: 83130067-83137264 TPBG Trophoblast glycoprotein precursor (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (5T4
oncofetal antigen) (M6P1).
RET 10: 117812943-118022969 GFRA1 GDNF family receptor alpha-1 precursor (GFR-alpha-1) (GDNF receptor alpha) (GDNFR-alpha) (TGF-beta-related
neurotrophic factor receptor 1) (RET ligand 1).
UBAP1 9: 34169003-34242521 UBAP1 Ubiquitin-associated protein 1 (UBAP).
FOS 14: 74815284-74818685 FOS Proto-oncogene protein c-fos (Cellular oncogene fos) (G0/G1 switch regulatory protein 7).
COPS5 8: 68117871-68136785 COPS5 COP9 signalosome complex subunit 5 (EC 3.4.-.-) (Signalosome subunit 5) (SGN5) (Jun activation domain-binding
protein 1).
Table 6: Colon cancer associated genes based on SNPs3D annotations. SNDs3D reference
column describes the name of the gene associated to colon cancer. The corresponding genes of
interesting regions are listed after the SNDs3D entry.
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CCS ref. locus gene name description
CSMD3 8: 113304337-114518418 CSMD3 CUB and sushi domain-containing protein 3 precursor (CUB and sushi multiple domains protein 3).
GNAS 20: 56848168-56919642 GNAS Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein).
GUCY1A2 11: 106063120-106394381 GUCY1A2 Guanylate cyclase soluble subunit alpha-2 (EC 4.6.1.2) (GCS-alpha-2).
PKHD1 6: 51588057-52060382 PKHD1 Polycystic kidney and hepatic disease 1 precursor (Fibrocystin) (Polyductin) (Tigmin).
RET 10: 117812943-118022969 GFRA1 GDNF family receptor alpha-1 precursor (GFR-alpha-1) (GDNF receptor alpha) (GDNFR-alpha) (TGF-
beta-related neurotrophic factor receptor 1) (RET ligand 1).
SCN3B 11: 123005107-123030165 SCN3B Sodium channel beta-3 subunit precursor.
Table 7: Colon cancer associated genes based on [Sjö06] annotations. CCS reference
column describes the name of the candidate cancer gene given in the article. The corresponding
genes of interesting regions are listed after the reference name entry.
Chromosome Start–End Genes
1 98190565–98214180
2 159328041–159328524
3 100986418–101207563 COL8A1, NP_997369.1,
C3orf26, NP_878913.2
4 165247274–165247492
5 85666781–85667222
5 86307720–86318185
6 93576978–93577084
6 95211104–95213139
7 80525620–80526424
7 116723355–116728976 WNT2
8 113348654–113368451 CSMD3
16 56409076–56409197
21 37379327–37439134 TTC3
Table 8: Interesting deletion condidates and overlapping genes that were found in CRC study.
The analysis of NoCall SNPs revealed 13 candidate sites of possible homozygous dele-
tions. The candidate sites consisted of at least two overlapping deletions in patient data,
whereas no deletions regions were accepted in reference samples. A region is considered
to be a deletion if it consisted of at least two reference SNPs or three SNPs in patient data.
The physical loci of the interesting regions are shown in Table 8. Genes overlapping the
interesting regions were fetched with RegionAnnotator and they have been listed on the
right most column of the table.
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8 Discussion
CohortComparator can be used as visualisation and comparison tool for two cohorts
analysed with high density SNP-microarrays. The genome wide analysis is thought to re-
quire over 105 SNPs but the resolution differences in samples with different origin can be
compensated using haplotype estimates of the population. The graphs of homozygous re-
gions and their allelic constitutions can be used to inspect common patterns of haplotypes
and the relationships between the samples. High rates of homozygosity may indicate
familiar relatedness of individuals’ parents. The relative amounts of homozygosity are
readily shown in CohortComparator graphs, which help in estimating the distribution.
The extensive size of the human genome leads to challenges in the visualisation of the
data. CohortComparator takes an approach of splitting the data into chromosome specific
graphs and highlighting the possibly interesting sample features based on their rareness
in references. The clear separation between long homozygous regions and homozygous
SNPs helps in concentrating into significant features of the data.
We found hidden Markov models unsuitable for detecting homozygous regions but they
have been successfully used in many genetic studies. Therefore, CohortComparator pro-
vides a framework for HMMs than can be used to detect genomic regions defined by the
two states of a given HMM. The framework provides a generic implementation of Viterbi
algorithm than calculates the most probable state sequence for the given HMM and an
emission sequence with the alphabet of the HMM. The transition probabilities can be
given in a form of a function of previous and following states and an index of the emis-
sion sequence value. The generalisation of the HMM transition probability matrix allows
the use of SNP specific transition probabilities, which may take the distances between the
SNPs into account.
The selection of proper reference samples is a crucial step as the comparison between the
data sets is extremely sensitive to references sharing the mutation in interest. The col-
orectal study was completed with a nil ( f .limit.r = 0) tolerance of homozygous alleles,
which means that a single reference sample with a latent susceptibility to CRC would
cover the site of mutation. The tolerance limit can be loosened as more reference samples
become available but some adjustments may be needed to work for low penetrance muta-
tions unless a higher penetrance is archived in association to another mutation. The high
penetrance combinations would be an interesting field of study but it requires a lot more
samples.
Feasible results were archived using the sliding window method with parameters: l = 55,
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w = 20, g = 0.05, and s = 2 (the parameters are given in SNPs instead of base pairs).
The homozygous regions produced were long enough to be biologically feasible but the
method was still capable of detecting short regions affecting single genes.
The list of possibly mutated genes produced by RegionAnnotator can be integrated with
expression microarray data produced from the patient samples associated to the regions.
The expression microarrays experiments are used to detect expression levels of various
genes. The genes that are not expressed in their normal concentrations in patient samples
are possibly inactivated by the inherited mutation. The comparison of RegionAnnotator
genes and the list of inactive genes combine the genetic information to the actual func-
tionality of the cells and separate the actively transcribed genes from the silent ones. The
silent genes are not necessarily damaged by a mutation but the inactivation may be due
the cellular state or a pure measurement error and the actively transcribed genes are not
necessarily working as they should if a mutation has altered their constitution in a ma-
lign manner. Still, the list of genes detected by RegionAnnotator and underexpressed in
expression studies is a good basis for further studies.
CohortComparator was applied to the colon cancer dataset and 2123 interesting regions
were found that may harbour a cancer exposing allele. The gene annotation of these re-
gions led to a list of 2257 possible genes of which 1643 genes were classified as known.
Experimental verification of these genes is a laborious and time-consuming task. The se-
quencing of the candidate genes of associated CRC samples is in progress and the results
of the verification will be published separately.
The 13 interesting sites of deletions suggested by the program were all confirmed to be
false positives based on the fact that the sequences around each SNP were replicating in
polymerase chain reaction experiments. The SNPs of the deletion sites expressed poor
hybridisations even in those samples that did not fail for all three continuous SNPs. The
observations suggest that the NoCall haplotypes are more likely to be technical artefacts
than real overlapping deletions in both chromosomes. The false discoveries can be elim-
inated by combining the region information to copy number analysis [Zha04]. The copy
numbers are not used within CohortComparator because that would have required the use
of probe intensities instead of genotypes. The genotype based approach has been chosen
to support various sources of data. The integration of the different modules, such as the
copy number tools, is compatible with our plan to build components that can be combined
together in a study specific manned.
The bioinformatics approach described in this thesis should be applicable to various stud-
ies of genetic origin of recessive phenotypes. CohortComparator will be publicly avail-
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able10 so that it can be tested and used in different studies. CSC has begun to optimise
my code for their computer clusters. Our aim is to have CohortComparator preinstalled
on CSC servers so that the Finnish biologists can use it together with other bioinformatic
tools they are already familiar.
The current version of CohortComparator does not take population haplotypes into ac-
count when it compares homozygous regions between the cohorts. The SNP vice compar-
ison of the regions may lead to fragments of interesting regions if a homozygous region
in case cohort consists of SNPs of the rare allele with some SNPS of the common allele
between them. Each sequence of common (sometimes caused by SNPs that do not vary
between the samples) genotypes may interrupt the interesting region as the same allele
becomes present in references. One common SNP genotype is capable of spliting an in-
teresting region into two fragments, which consequently lowers the scoring of the region.
We are planning to find better solutions to this challenge in near future.
10The official home page of CohortComparator is
http://www.ltdk.helsinki.fi/sysbio/csb/downloads/CohortComparator/.
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1Appendix 1. Graphs of Interesting Regions
This appendix contains visualisations of SNPs in chromosome 5. The figures are gener-
ated using different parameter and data set combinations to illustrate some aspects of the
analysis. The appendix can be used to get an idea of CohortComparator without a local
installation and data sets.
CohortComparator can generate PostScript images of its results. Each chromosome is
shown in its own image x-axis representing the nucleotide position from the first SNP to
the last one. The samples are shown in rows so that the reference samples are at the top
and the experimental data is at the bottom. Experimental samples are sorted based on the
total length of heterozygous regions within the chromosome and the top most is the one
with the greatest value.
Allele colours of the homozygous regions have been chosen so that red represents the
allele present in homozygous regions found from the references or aa if the frequencies
of aa and bb are equal. Blue allele is the one that is not so common in references and thus
it is more interesting when present in experimental data. The blue regions are favoured
over the red ones in their length so that they expand all the way to the first red SNP. Dark
violet have been used as a compromise in those experimental regions that have no colour
determining SNPs, which means that they are on a region without homozygous regions
in reference set. Two dark violet regions may differ in their allelic constitution indepen-
dently. Regions with possibly interesting differences have been emphasized with vertical
blocks covering the regions. Homozygosity have been marked with yellow, deletions
with green, and exceptional alleles with orange. CohortComparator has a score limit
option that can be used to drop interesting regions below the given limit but the limit of 0
has been used for all graphs in this thesis. An optional detection of compound heterozy-
gotes is used in Figure 21 where they have been shown in gray as overlapping interesting
regions.
The following list explains the parameters and the data that are used in the graphs of this
appendix.
• Figure 21 illustrates typical results with the parameters that were used in initial stud-
ies of homozygosity. Two tiny green lines that are almost invisible are over the hor-
izontal black line separating the data sets. Positions of these lines are: 59741074–
59810894 and 101298106–101298106 and they represent interesting regions with
no compound heterozygotes on references.
2• Figure 22 contains the same data as in Figure 21 but the missing values such as
HindIII SNPs in reference samples and all NoCall SNP in all samples are estimated
using fastPHASE haplotyping software. The same parameters were used for both
data sets as they have the same resolution. The amount of short regions that were
likely to be false discoveries has diminished in reference set leading to an expansion
of the interesting regions.
• Figure 23 has been created with almost same parameters as Figure 21 but l and w
were given in base pairs instead of SNPs. The limit l was estimated so that it was
of the same fold with the shortest regions found in patient data of Figure 24.
• Figure 24 represents the comparison of chromosome 5 of the colon cancer patients
to themselves. The reference set consists of XbaI chip data whereas the data set
consists of both XbaI and HindIII measurements.
• Figure 25 is exactly the same as Figure 24 but now the reference consists of both
XbaI and HindIII measurements and the data set consists of XbaI SNPs. The dif-
ference between these two images is huge suggesting that there are many false
positives when the HindIII data is ignored.
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1Appendix 2. Parameters of CohortComparator
All input parameters of CohortComparator are given in a separate R source file called
homozygous.properties, which should be kept in the CohortComparator working di-
rectory. A short description of each parameter is given in here to bind the nomenclature
of this document and the application.
chromosome.range List of chromosome numbers for the genomic range of in-
terest
bpLength TRUE if l and w are given in base pairs and FALSE if they are
given in SNPs
d.limit.d Minimum number of continuous NoCall SNPs in data set
considered to be a deletion
d.limit.r Same as d.limit.d but for the reference set
doCompound TRUE for activating the analysis of compound heterozygos-
ity
doInter This Boolean is used by the result file compari-
son tool. TRUE gives the intersection of regions
in files out.file.res.c1 and out.file.res.c2 and
FALSE substracts regions of out.file.res.c2 out of
out.file.res.c1.
f.limit.d The minimum amount of overlapping features required in
patient data for an interesting region (tD) / nD
f.limit.r The maximum amount of overlaping features that can be
ignored in reference set (tR) / nR
gapRate.d gD or (wD, gD) for sliding window
gapRate.r gR or (wR, gR) for sliding window
HR_cfg_version Version number of CohortComparator compatible with the
configuration file
l.limit.d lD
l.limit.r lR
maxGap.d Maximal length of a hetorozygous section within a homozy-
gous region in patient data (sD)
maxGap.r Maximal length of a hetorozygous section within a homozy-
gous region in reference set (sR)
2out.file.results File name for the list of interesting regions and related
scores with sample names
out.file.res.c1 This Boolean is used by the result file comparison tool to
give the file name of the first list of interesting regions.
out.file.res.c2 This Boolean is used by the result file comparison tool to
give the file name of the second list of interesting regions.
out.folder Directory name for the output files
region.def Definition of homozygous region: hidden Markov model
(hmm), gap distance (dist), gap ratio (ratio), or sliding
window (window).
ref.height Rendering parameter that tells the relative height of sample
rows in references compared to those in data set
rID An output file prefix for the files identifying the run
score.limit An integer limit for the scores of interesting regions to be
visualised in graphs. All regions will be shown if the limit
is less than or equal to 0.
scoring.method Either “fraction” or “total” depending of the chosen method
of calculating scores of interesting regions as explained in
Section 4.3
src.folder Directory name for the input files
src.prefix.data File name prefix for the data set SNP files
src.prefix.locD File name prefix for the chromosome specific list of physi-
cal locations of SNPs in data set haplotype matrix
src.prefix.locR File name prefix for the chromosome specific list of physi-
cal locations of SNPs in reference set haplotype matrix
src.prefix.refs File name prefix for the reference set SNP files
